US20200376191A1 - Ratchet drive for on body delivery system - Google Patents
Ratchet drive for on body delivery system Download PDFInfo
- Publication number
- US20200376191A1 US20200376191A1 US16/995,527 US202016995527A US2020376191A1 US 20200376191 A1 US20200376191 A1 US 20200376191A1 US 202016995527 A US202016995527 A US 202016995527A US 2020376191 A1 US2020376191 A1 US 2020376191A1
- Authority
- US
- United States
- Prior art keywords
- arm
- ratchet
- carrier
- rack
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940079593 drug Drugs 0.000 claims abstract description 171
- 239000003814 drug Substances 0.000 claims abstract description 171
- 239000007788 liquid Substances 0.000 claims abstract description 93
- 238000012377 drug delivery Methods 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims description 11
- 230000003213 activating effect Effects 0.000 claims description 2
- 230000004913 activation Effects 0.000 description 7
- 238000006073 displacement reaction Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 208000003870 Drug Overdose Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010033296 Overdoses Diseases 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 231100000725 drug overdose Toxicity 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16804—Flow controllers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16877—Adjusting flow; Devices for setting a flow rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
- A61M2005/14533—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons cam actuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31535—Means improving security or handling thereof, e.g. blocking means, means preventing insufficient dosing, means allowing correction of overset dose
- A61M5/31536—Blocking means to immobilize a selected dose, e.g. to administer equal doses
- A61M2005/3154—Blocking means to immobilize a selected dose, e.g. to administer equal doses limiting maximum permissible dose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31535—Means improving security or handling thereof, e.g. blocking means, means preventing insufficient dosing, means allowing correction of overset dose
- A61M5/31536—Blocking means to immobilize a selected dose, e.g. to administer equal doses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31545—Setting modes for dosing
- A61M5/31546—Electrically operated dose setting, e.g. input via touch screen or plus/minus buttons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31566—Means improving security or handling thereof
- A61M5/31568—Means keeping track of the total dose administered, e.g. since the cartridge was inserted
Definitions
- Embodiments generally relate to medication delivery. More particularly, embodiments relate to drive systems for drug delivery devices.
- An on-body delivery system can be used to deliver drug dosages to a user over time.
- OBDS on-body delivery system
- an OBDS having a drive system for delivering a drug to a user that can prevent delivery of too much of a drug to the user during a system failure.
- FIG. 1 illustrates a first exemplary ratchet drive system.
- FIG. 2 illustrates the first ratchet drive system in an idle state.
- FIG. 3 illustrates the first ratchet drive system during delivery of a drug.
- FIG. 4 illustrates the first ratchet drive system after delivery of the drug.
- FIG. 5 illustrates the first ratchet drive system during a first phase of reset.
- FIG. 6 illustrates the first ratchet drive system during a second phase of reset.
- FIG. 7 illustrates the first ratchet drive system in relation to a controller.
- FIG. 8 illustrates a second exemplary ratchet drive system.
- FIG. 9 illustrates the second ratchet drive system after delivery of a drug.
- FIG. 10 illustrates the first ratchet drive system in relation to a drug container.
- FIG. 11 illustrates a third exemplary ratchet drive system.
- FIG. 12 illustrates the third ratchet drive system in an idle state.
- FIG. 13 illustrates the third ratchet drive system during delivery of a drug.
- FIG. 14 illustrates the third ratchet drive system after delivery of the drug during a first phase of reset.
- FIG. 15 illustrates the third ratchet drive system during a second phase of reset.
- FIG. 16 illustrates a fourth ratchet drive system during delivery of a drug.
- FIG. 17 illustrates the fourth ratchet drive system after delivery of the drug during a first phase of reset.
- FIG. 18 illustrates the fourth ratchet drive system during a second phase of reset.
- FIG. 19 illustrates the first ratchet drive system in relation to a power source.
- This disclosure presents various systems, components, and methods related to a drug delivery device.
- Each of the systems, components, and methods disclosed herein provides one or more advantages over conventional systems, components, and methods.
- ratchet-based drive systems restrict angular movement and/or linear movement of components that cause a plunger to expel a liquid drug from a drug container. Movement of the components can be restricted to expel only a predetermined or desired amount of the liquid drug. In the case that control of the drive system is lost or fails, the maximum amount of drug that could be delivered is limited to a known amount, thereby reducing the likelihood of an overdose.
- the predetermined amount of the liquid drug expelled can correspond to any portion of the liquid drug including a single dose of the liquid drug or a portion thereof.
- FIG. 1 illustrates a first exemplary ratchet drive system 100 .
- the ratchet drive system 100 can be incorporated as part of an on-body delivery system (OBDS) as described herein.
- the ratchet drive system 100 can include a lead screw 102 , a ratchet gear 104 , a ratchet carrier 106 , a first pawl 108 - 1 , a second pawl 108 - 2 , a first carrier stop 110 - 1 , and a second carrier stop 110 - 2 .
- OBDS on-body delivery system
- the lead screw 102 can be coupled to the ratchet gear 104 and can be positioned through the ratchet gear 104 (e.g., through a center hole of the ratchet gear 104 ).
- the lead screw 102 can include threads that engage the ratchet gear 104 .
- the lead screw 102 can also be positioned through the ratchet carrier (e.g., through a center hole of the ratchet carrier 106 ).
- An end of the lead screw 102 that extends beyond the ratchet carrier 106 can be coupled to a plunger positioned within a drug cartridge (not shown in FIG. 1 ).
- the ratchet drive system 100 can be operated such that rotation of the lead screw 102 can cause the plunger to be advanced, thereby expelling a portion of a liquid drug stored in the drug cartridge.
- the ratchet drive system 100 can prevent over-delivery (e.g., overdose) of the liquid drug (e.g., during system failure of the OBDS incorporating the ratchet drive system 100 ) to ensure safe delivery of the liquid drug and operation of the OBDS as described herein.
- the first and second pawls 108 - 1 and 108 - 2 can be coupled to the ratchet carrier 106 . As shown in FIG. 1 , the first and second pawls 108 - 1 and 108 - 2 can be positioned to engage the ratchet gear 104 (e.g., the outer teeth of the ratchet gear 104 ). To expel a portion of the liquid drug from the drug container, the ratchet carrier 104 can be rotated (e.g., about a central axis of rotation 114 in a clockwise direction with respect to the depiction of the ratchet drive system 100 in FIG. 1 ).
- the ratchet carrier 104 can be rotated (e.g., about a central axis of rotation 114 in a clockwise direction with respect to the depiction of the ratchet drive system 100 in FIG. 1 ).
- the ratchet carrier 106 can be rotated by an amount corresponding to the position of the second carrier stop 110 - 2 . That is, the ratchet carrier 106 can be rotated such that an extension or protrusion 112 of the ratchet carrier 106 moves from the first carrier stop 110 - 1 to the second carrier stop 110 - 2 .
- the extension 112 of the ratchet carrier 106 can be stopped by or can be positioned adjacent to the second carrier stop 110 - 2 when a desired portion (e.g., a dose or portion thereof) of the liquid drug has been expelled from the drug container.
- the first and second carrier stops 110 - 1 and 110 - 2 can be coupled to a portion of the OBDS incorporating the ratchet drive system 100 .
- Rotation of the lead screw 102 can cause the lead screw 102 to advance in a direction 116 that can be parallel to the central axis 114 .
- This movement of the lead screw 102 can cause the plunger to move further into the drug container, which can cause a portion of the liquid drug stored therein to be expelled.
- the linear displacement of the lead screw 102 in the direction 116 caused by rotation of the ratchet carrier 106 and the ratchet gear 104 can be based on a thread pitch of the lead screw 102 which can be adjusted for particular applications and drug dosages.
- the amount of liquid drug expelled can correspond to a predetermined or desired amount of the liquid drug stored in the drug container.
- any portion of the liquid drug can be expelled including, for example, a single dose of the liquid drug or a portion thereof. Accordingly, in various embodiments, movement of the ratchet carrier 106 from the first carrier stop 110 - 1 to the second carrier stop 110 - 2 can cause a single dose of the liquid drug to be expelled from the drug container for delivery to a patient or user.
- the ratchet carrier 106 can be rotated back to a position corresponding to the first carrier stop 110 - 2 (e.g., as shown in FIG. 1 ).
- the ratchet drive system 100 can be in an initial or reset state awaiting activation so as to rotate the ratchet carrier 106 toward the second carrier stop 110 - 2 for delivery of a portion of the liquid drug.
- the ratchet carrier 106 Prior to rotating the ratchet carrier 106 back to a position corresponding the first carrier stop 110 - 1 as shown in FIG.
- the first and second pawls 108 - 1 and 108 - 2 can be disengaged from the ratchet gear 104 .
- Releasing the first and second pawls 108 - 1 and 108 - 2 from the ratchet gear 104 can prevent the ratchet gear 104 from rotating when the ratchet carrier 106 is rotated back toward the first carrier stop 110 - 1 .
- the position of the lead screw 102 is maintained (e.g., the lead screw 102 is not advanced in the direction 116 when the ratchet carrier 106 is rotated back toward the first carrier stop 110 - 1 ).
- the first and second pawls 108 - 1 and 108 - 2 can then re-engage the ratchet gear 104 after the ratchet carrier 104 is moved back to the position shown in FIG. 1 .
- the ratchet drive system 100 can then await a subsequent activation (e.g., an instruction to rotate the ratchet carrier 106 toward the second carrier stop 110 - 2 ) for a next cycle of drug delivery.
- the first and second pawls 108 - 1 and 108 - 2 can be coupled to a control system that can rotate or otherwise adjust the position of the first and second pawls 108 - 1 and 108 - 2 to engage and disengage the ratchet gear 104 as desired.
- the ratchet carrier 106 can be positioned around the ratchet gear 104 .
- the ratchet gear 104 can be positioned within an opening of the ratchet carrier 106 .
- the ratchet drive system 100 can include a single pawl or more than two pawls.
- the operation of the ratchet drive system 100 can prevent over-delivery of the liquid drug that the ratchet drive system 100 can be used to expel from the drug container.
- the second carrier stop 110 - 2 can prevent the lead screw 102 from rotating more than a desired amount, by restricting further rotation of the ratchet carrier 106 , thereby restricting further advancement of the plunger coupled to the lead screw 102 . As a result, further delivery of the liquid drug is prevented.
- the OBDS that incorporates the ratchet drive system 100 (e.g., a power failure)
- Precise dosing of the liquid drug can also be provided by the ratchet drive system 100 .
- the first and second carrier stops 110 - 1 and 110 - 2 can be displaced by any amount. As shown in FIG. 1 , the first and second carrier stops 110 - 1 and 110 - 2 are displaced by approximately 180 degrees but are not so limited. The displacement of the first and second carrier stops 110 - 1 and 110 - 2 can correspond to delivery of a predetermined or desired amount of the liquid drug when the ratchet carrier 106 is rotated from the first carrier stop 110 - 1 to the second carrier stop 110 - 2 but is not so limited. In various embodiments, the predetermined amount of the liquid drug can correspond to a single dose of the liquid drug or a portion thereof.
- the ratchet carrier 106 can be coupled to a power source to effectuate rotation of the ratchet carrier 106 .
- the power source can comprise a motor but is not so limited.
- the power source can comprise a mechanical system or an electromechanical system.
- the power source can cause the ratchet carrier 106 to be rotated toward the second carrier stop 110 - 1 based upon an activation signal provided by the OBDS (e.g., a controller).
- the activation can be automatically provided or can be generated responsive to a user input.
- the power source can cause the ratchet carrier 106 to rotate back toward the first carrier stop 110 - 1 immediately after providing the dosage of the liquid drug or after a predetermined delay.
- the OBDS in which the ratchet drive system 100 can be incorporated can be any type of wearable drug delivery system such as, for example, the OmniPod® (Insulet Corporation, Billerica, Mass.) insulin delivery device and/or a drug delivery device such as those described in U.S. Pat. Nos. 7,303,549, 7,137,964, or U.S. Pat. No. 6,740,059, each of which is incorporated herein by reference in its entirety.
- the OmniPod® Insulet Corporation, Billerica, Mass.
- a drug delivery device such as those described in U.S. Pat. Nos. 7,303,549, 7,137,964, or U.S. Pat. No. 6,740,059, each of which is incorporated herein by reference in its entirety.
- FIG. 2 illustrates a second view of the ratchet drive system 100 depicted in FIG. 1 .
- FIG. 1 can represent an isometric view of the ratchet drive system 100 .
- FIG. 2 can represent a corresponding front view of the ratchet drive system 100 .
- the extension 112 can be positioned adjacent to the first carrier stop 110 - 1 and the first and second pawls 108 - 1 and 108 - 2 can be engaged with the ratchet gear 104 .
- FIG. 2 can represent the ratchet drive system 100 in an initial or idle state prior to being activated to rotate the ratchet carrier 106 . Further, the ratchet carrier 106 can be considered to be in an initial position as depicted in FIG. 2 .
- FIG. 3 illustrates a front view of the ratchet drive system 100 during delivery of the liquid drug.
- the ratchet carrier 106 is rotated in a direction 302 (e.g., a clockwise direction relative to the depiction of the ratchet drive system 100 in FIG. 3 ).
- the extension 112 is moving toward the second carrier stop 110 - 2 .
- the first and second pawls 108 - 1 and 108 - 2 , the ratchet gear 104 , and the lead screw 102 each correspondingly rotate in the direction 302 .
- the lead screw 102 is linearly displaced in a direction parallel to the central axis 114 .
- FIG. 4 illustrates a front view of the ratchet drive system 100 after delivery of the liquid drug.
- the ratchet carrier 106 has been rotated such that the extension 112 is positioned adjacent to the second carrier stop 110 - 2 .
- the second carrier stop 110 - 2 can prevent the ratchet carrier 106 from rotating any further, thereby preventing further linear displacement of the lead screw 102 .
- the rotation of the ratchet carrier 106 from the first carrier stop 110 - 1 to the second carrier stop 110 - 2 can correspond to expelling and delivering a desired amount or portion of the liquid drug.
- the ratchet carrier 106 can be considered to be in a final position as depicted in FIG. 4 .
- FIG. 5 illustrates a front view of the ratchet drive system 100 during an initial resetting of the ratchet drive system 100 .
- the first and second pawls 108 - 1 and 108 - 2 are disengaged from the ratchet gear 104 .
- the ratchet gear 104 and the lead screw 102 will remain stationary.
- none of the liquid drug will be expelled from the drug container when the ratchet carrier 106 is rotated back towards the first carrier stop 110 - 1 .
- FIG. 6 illustrates a front view of the ratchet drive system 100 during further resetting of the ratchet drive system 100 .
- the ratchet carrier 106 is rotated in a direction 602 (e.g., a counter-clockwise direction relative to the depiction of the ratchet drive system 100 in FIG. 6 ).
- the extension 112 is moved toward the first carrier stop 110 - 1 and is shown positioned adjacent to the first carrier stop 110 - 1 (e.g., corresponding to the initial position of the ratchet carrier 106 ).
- the first and second pawls 108 - 1 and 108 - 2 are similarly rotated in the direction 602 .
- the first and second pawls 108 - 1 and 108 - 2 can re-engage the ratchet gear 104 (e.g., as depicted in FIG. 2 ).
- the ratchet drive system 100 can then remain in the reset or idle state until being activated again to repeat delivery and the reset cycle as described herein.
- the first carrier stop 110 - 1 can also restrict further rotation of the ratchet carrier 106 .
- FIG. 7 illustrates the ratchet drive system 100 with an exemplary controller 702 .
- the controller 702 can be coupled to the first carrier stop 110 - 1 , the second carrier stop 110 - 1 , and any other component of the ratchet drive system 100 such as the ratchet carrier 106 .
- the controller 702 can direct operation of the ratchet drive system 100 .
- the first and second carrier stops 110 - 1 and 110 - 2 can each include one or more sensors that can inform the controller 702 as to the position of the ratchet carrier 106 .
- first and second carrier stops 110 - 1 and 110 - 2 can each include a sensor that can inform the controller 702 when the extension 112 is touching or in close proximity to one of the first and second carrier stops 110 - 1 and 110 - 2 .
- Positional information of the ratchet carrier 106 can also be provided to the controller 702 from rotation of the ratchet carrier 106 .
- the controller 702 can be coupled to the power source of the ratchet drive system 100 to direct the power source to rotate the ratchet carrier 106 in a desired direction based on, for example, positional information of the ratchet carrier 106 provided by at least the first and second carrier stops 110 - 1 and 110 - 2 .
- the senor in the second carrier stop 110 - 2 can send a signal to the controller 702 indicating the position of the extension 112 (e.g., when the extension touches or is adjacent to the second carrier stop 110 - 2 ).
- the controller 702 can adjust or stop the rotation of the ratchet carrier 106 (e.g., in the direction 302 ) based on signals received from the second carrier stop 110 - 2 . Further, signals from the second carrier stop 110 - 2 can allow the controller 702 to maintain a count of the number of times the extension 112 has reached the second carrier stop 110 - 2 .
- a count of the number of times the drug is delivered or expelled can be maintained, along with a count of the remaining number of times the drug can be expelled.
- a count of the number of doses of drug delivered or expelled can be maintained, along with a count of remaining doses.
- the sensor in the first carrier stop 110 - 1 can similarly send a signal to the controller 702 indicating the position of the extension 112 (e.g., when the extension touches or is adjacent to the first carrier stop 110 - 1 ).
- the controller 702 can adjust or stop the rotation of the ratchet carrier 106 (e.g., in the direction 602 ) based on signals received from the first carrier stop 110 - 1 .
- Signals from the first carrier stop 110 - 1 can also be used to maintain a count of the number of times the liquid drug is delivered or expelled and a count of how many more times the drug can be expelled before the drug container is substantially empty.
- the signals from the first carrier stop 110 - 1 can enable a count of the number of doses of drug delivered or expelled can be maintained, along with a count of remaining doses.
- FIG. 8 illustrates a second exemplary ratchet drive system 800 .
- the ratchet drive system 800 can include substantially the same components of the ratchet drive system 100 and can operate in a substantially similar manner as the ratchet drive system 100 .
- the ratchet drive system 800 can include a single carrier stop 802 (as opposed to two carrier stops as included with the ratchet drive system 100 ).
- the ratchet drive system 800 as shown in FIG. 8 can be in an initial position or idle state prior to being activated to deliver a portion of the liquid drug.
- the ratchet carrier 106 can rotate in a clockwise direction (relative to the depiction of the ratchet drive system 800 in FIG.
- the extension 112 can rotate until reaching the other side of the carrier stop 802 . In doing so, the ratchet gear 104 and the lead screw 102 can similarly rotate. A desired amount of drug can be expelled from the drug container based on this rotation of the ratchet carrier 106 .
- the carrier stop 802 can include one or more sensors for detecting a position of the ratchet carrier 106 .
- the ratchet drive system 800 can further include a controller for directing operation of the ratchet drive system 800 based on signals received from one or more sensors of the carrier stop 802 .
- the ratchet drive system 800 can be coupled to a power source (e.g., a motor) to provide an input for rotating the ratchet carrier 106 .
- FIG. 9 illustrates the ratchet drive system 800 after delivering a portion of the liquid drug.
- the ratchet carrier 106 has rotated such that the extension 112 is positioned on the other side of the carrier stop 802 (as compared to the position of the extension 112 as shown in FIG. 8 ).
- the first and second pawls 108 - 1 and 108 - 2 and the ratchet gear 104 have similarly rotated.
- the ratchet carrier 106 has rotated just under 360 degrees.
- the implementation of the ratchet drive system 800 with the single carrier stop 802 can reduce the number of motor cycles used to deliver the same advancement of the lead screw 102 .
- FIG. 10 illustrates a side view of the ratchet drive system 100 in relationship to a drug container 1002 .
- the first and second carrier stops 110 - 2 and 110 - 2 are not shown.
- the lead screw 102 extends through and beyond the ratchet carrier 106 (e.g., through a central hole or opening of the ratchet carrier 106 ).
- the ratchet carrier 106 can be coupled to or positioned adjacent to the drug container 1002 .
- the drug container 1002 can include an area or reservoir 1004 for holding a liquid drug as described herein.
- the drug container 1002 can further include a port 1006 through which the liquid drug stored in the reservoir 1004 can be expelled out of the drug container 1002 .
- the lead screw 102 can be coupled to a plunger 1008 .
- the plunger 1008 can define a boundary of the reservoir 1004 .
- the lead screw 102 can rotate about the central axis 114 .
- the lead screw 102 can move in the direction 116 and can push on the plunger 1008 to drive the plunger 1008 in the direction 116 as well.
- the movement of the plunger 1008 in the direction 116 can expel a portion of the liquid drug stored in the reservoir 1004 from the drug container 1002 (e.g., through the exit port 1006 for subsequent delivery to a patient).
- the ratchet drive system 100 and additional components depicted in FIG. 10 can be incorporated into an OBDS as described herein.
- the ratchet drive system 800 can be similarly coupled to the additional components depicted in FIG. 10 as will be understood by a person of ordinary skill in the art.
- the ratchet drive systems 100 and 800 can prevent overdose situations that can occur with conventional drive systems for drug delivery devices by restricting rotational movement and using multiple rotational cycles to deliver one or more desired or predetermined doses of the liquid drug.
- the second carrier stop 110 - 2 can restrict the angular movement of the ratchet carrier 106 .
- delivery of any further drug can be prevented.
- the second carrier stop 110 - 2 can block movement of the ratchet carrier 106 that could be caused by any force such as inertia or gravity that may attempt to rotate the ratchet carrier 106 any further.
- the maximum angular movement of the ratchet carrier 106 can be restricted by a desired amount such that the angular displacement corresponds to a desired drug delivery, ensuring that drug delivery can be limited to a desired amount in a runaway operation condition.
- any portion of the stored liquid drug can be delivered during each cycle of movement including, for example, a single desired dose of the liquid drug or a portion thereof.
- the ratchet drive system 800 provides the same prevention of overdose during such conditions by the carrier stop 802 similarly restricting movement of the ratchet carrier 106 .
- FIG. 19 illustrates the ratchet drive system 100 with an exemplary power source 1906 .
- the power source 1906 can be a motor.
- the motor 1906 can interface with the ratchet drive system 100 as shown to facilitate movement of the ratchet carrier 106 as described herein.
- the ratchet carrier 106 can include gear teeth 1902 .
- the gear teeth 1902 can be positioned along a perimeter of the ratchet carrier 106 and can project from the ratchet carrier 106 .
- a gear 1904 can be coupled to the ratchet carrier 106 as shown.
- teeth of the gear 1904 can interface with the gear teeth 1902 of the ratchet carrier 106 .
- the gear 1904 can be coupled to the motor 1906 .
- the motor 1906 can rotate the ratchet gear 1906 as desired and as described herein by rotation of the gear 1904 as will be understood by a person of ordinary skill in the art. Accordingly, the motor 1906 can control delivery of the liquid drug by rotating the ratchet carrier 106 as desired and can rotate the ratchet carrier 106 back to an idle state after delivery.
- the motor 1906 can initiate rotation automatically or based on user input.
- the ratchet drive systems 100 and 800 can be configured to enable a portion of the drug to be delivered based on both forward and backwards rotation of the ratchet carrier 106 as will be appreciated by one skilled in the art.
- FIG. 11 illustrates a third exemplary ratchet drive system 1100 .
- the ratchet drive system 1100 can be used in an OBDS as described herein.
- the ratchet drive system 1100 can include a rack 1102 , a plunger 1104 , a power source 1106 , an arm 1108 , a pawl 1110 , and a drug container 1112 .
- the rack 1102 can be coupled to the plunger 1104 .
- the plunger 1104 can be positioned within the drug container 1112 .
- the power source 1106 can be, for example, a motor or a linear actuator.
- the power source 1106 can be coupled to the arm 1108 .
- the pawl 1110 can be coupled to the arm 1108 .
- the ratchet drive system 1100 can be operated such that linear movement of the arm 1108 (e.g., in a direction away from the power source 1106 ) can drive the plunger 1104 further into the drug container 1112 , thereby expelling a portion of a liquid drug stored in the drug cartridge.
- the ratchet drive system 1100 can prevent over-delivery (e.g., overdose) of the liquid drug (e.g., during system failure of the OBDS incorporating the ratchet drive system 1100 ) to ensure safe delivery of the liquid drug and operation of the OBDS as described herein.
- FIG. 11 can represent the ratchet drive system 1100 in an idle state prior to activation.
- the ratchet drive system 1100 can operate to deliver a desired amount of the stored liquid drug to a user.
- the power source 1106 can cause the arm 1108 to extend (e.g., in a direction away from the power source 1106 ).
- the rack 1102 can be caused to move forward (e.g., in the same direction that the arm 108 extends) by the coupling of the arm 1108 to the rack 1102 by the pawl 1110 .
- the plunger 1104 is driven further into the drug container, expelling a portion of the stored liquid drug.
- the arm 1108 can be sized and controlled to extend a desired amount away from the power source 1106 when the ratchet drive system 1100 is activated. By limiting the amount by which the arm 1108 can extend (e.g., to a maximum extension amount), the movement of the plunger 1104 can likewise be limited. In this way, over-delivery can be mitigated by limiting the amount of liquid drug that can be expelled during each activation of the ratchet drive system 1100 . After the arm 1108 is fully extended, the arm 1108 can be operated to move back to its original position (e.g., retracted back toward the power source 1106 ). The position of the rack 1102 can be maintained by having the pawl 1110 disengage the rack 1102 prior to the arm 1108 moving in a direction back toward the power source 1108 .
- the ratchet drive system 1100 can be used with the same OBDSs described in relation to the ratchet drive systems 100 and 800 .
- a controller can be used with the ratchet drive system 1100 to direct operation of the power source 1106 and therefore delivery of the liquid drug.
- the controller can direct operation of the power source 1106 based on, for example, positional information of the plunger 1104 , the rack 1102 , and/or the arm 1108 .
- the controller can track delivery of the liquid drug to determine a number of times a portion of the drug is delivered and/or an amount of liquid drug remaining as described herein, for example based on the movement of the arm 1108 .
- the drug container 1112 like the drug container 1002 , can include a port for the liquid drug (not shown in FIG. 11 ).
- FIG. 12 illustrates a second view of the ratchet drive system 1100 depicted in FIG. 11 .
- FIG. 11 can represent an isometric view of the ratchet drive system 1100 .
- FIG. 12 can represent a corresponding side view of the ratchet drive system 1100 .
- the pawl 1110 couples the arm 1108 to the rack 1102 .
- the drug container 1112 includes a reservoir 1202 for storing the liquid drug.
- the reservoir 1202 can be defined in part by the plunger 1104 and an end of the drug container (opposite to the plunger 1104 ; not shown in FIG. 12 ).
- the end of the drug container 1112 can include a port or other opening allowing the liquid drug stored in the reservoir 1202 to be expelled as the plunger 1104 is advanced toward the end of the drug container 1112 .
- FIG. 13 illustrates the ratchet drive system 1100 during delivery of the liquid drug.
- the arm 1108 extends in a direction 1302 .
- the rack 1102 and plunger 1104 are advanced in a direction 1304 as shown.
- the advancement of the plunger 1104 further into the drug container 1112 can cause a portion of the liquid drug stored in the reservoir 1202 to be expelled from the drug container 1112 .
- the arm 1108 can be sized such that extension of the arm 1108 in the direction 1302 corresponds to a desired amount of the liquid drug being expelled (e.g., a single dose or a portion thereof).
- the length of the arm 1108 can be limited such that only a desired amount of the liquid drug is expelled by moving the rack 1102 and the plunger 1104 by the amount the arm 1108 is extended. Runaway operation and over-delivery of the liquid drug can therefore be avoided in case of a system failure (e.g., power loss) of the OBDS in which the ratchet drive system 1100 is incorporated since further movement of the rack 1102 by the arm 1108 is restricted.
- a system failure e.g., power loss
- the controller can track the movement of the arm 1008 and can maintain a count of the number of times the arm 1108 is extended to expel the liquid drug.
- the amount the arm 1108 is extended can correspond to any desired amount of drug to be delivered to a user including, for example, a single dose of the liquid drug, or a portion thereof.
- FIG. 14 illustrates the ratchet drive system 1100 initiating a return to its initial or idle state.
- the arm 1108 is a moved in a direction 1402 back toward the power source 1106 .
- the pawl 1110 is shaped so as to rotate in a direction 1404 as the arm 1108 is moved in the direction 1402 .
- the pawl 1110 is disengaged from the rack 1102 .
- the rack 1102 therefore does not move and remains stationary as the arm 1108 is moved backwards (e.g., in the direction 1402 ).
- the pawl 1110 can be controlled to rotate in the direction 1404 to facilitate disengagement from the rack 1102 .
- the arm 1108 can be retracted back to an original position corresponding to the position of the arm 1108 prior to activation.
- FIG. 15 illustrates the ratchet drive system 1100 re-engaging the rack 1102 .
- the arm 1108 is in close proximity to the power source 1106 .
- the pawl 1110 rotates in a direction 1502 to re-engage the rack 1102 .
- the ratchet drive system 1110 can be re-activated to a deliver a subsequent amount of the liquid drug.
- the stroke of the arm 1108 can be greater than a length of one tooth on of the rack 1102 so as to provide clearance for the pawl 1110 to rotate as described herein without hitting a tooth of the rack 1102 .
- the rotational movement of the pawl 1110 and/or the linear movement of the pawl 1110 can be passive movements, as the angle of the rack 1102 can push the pawl 1110 out of the way.
- the pawl 1110 can be spring loaded, for example, and biased to be in the engaged position as shown in FIG. 15 .
- the pawl 1110 can be actively rotated as desired for retraction, using a separate power source for example.
- the ratchet drive system 1100 can also prevent overdose situations that can occur with conventional drive systems for drug delivery devices by restricting linear movement and using multiple actuations cycles to deliver one or more doses of the liquid drug. For example, if the power source 1108 suddenly and/or catastrophically fails at any time (e.g., during delivery of a dose and/or when the arm 1108 is being extended), then the length of the arm 1108 (e.g., maximum extension of the arm 1108 ) can restrict the amount by which the rack 1102 and the plunger 1104 can move. As a result, delivery of any further drug can be prevented.
- the power source 1108 suddenly and/or catastrophically fails at any time (e.g., during delivery of a dose and/or when the arm 1108 is being extended)
- the length of the arm 1108 e.g., maximum extension of the arm 1108
- delivery of any further drug can be prevented.
- FIG. 16 illustrates a fourth exemplary ratchet drive system 1600 .
- the ratchet drive system 1600 can be a variation of the ratchet drive system 1100 .
- the ratchet drive system 1600 can be used in an OBDS as described herein and can provide the same benefits as the ratchet drive system 1600 .
- the ratchet drive system 1600 can include the rack 1102 , the plunger 1104 , the power source 1106 , the arm 1108 , a pawl 1606 , and the drug container 1112 .
- the ratchet drive system 1600 can operate in a substantially similar manner as the ratchet system 1100 with the exceptions described herein.
- the pawl 1606 can be coupled to the arm 1108 .
- the pawl 1606 can be coupled to the arm 1108 and arranged to move up and down (e.g., towards and away from the rack 1102 ) to engage and disengage from the rack 1102 as described further herein.
- FIG. 16 illustrates the ratchet drive system 1600 during delivery of the liquid drug.
- the arm 1108 extends in a direction 1602 and the pawl 1606 is engaged with the rack 1102 .
- the rack 1102 and the plunger 1104 are advanced in a direction 1604 as shown.
- the advancement of the plunger 1104 further into the drug container 1112 can cause a portion of the liquid drug stored in the reservoir 1202 to be expelled from the drug container 1112 as described above in relation to the ratchet drive system 1100 .
- the arm 1108 is extended by a desired or predetermined amount, the arm 1108 and the rack 1102 can come to rest.
- FIG. 17 illustrates the ratchet drive system 1600 initiating a return to its initial or idle state.
- the arm 1108 is moved in a direction 1702 back toward the power source 1106 .
- the pawl 1606 can move downward in a direction 1704 as the arm 1108 is moved in the direction 1702 .
- the pawl 1606 is disengaged from the rack 1102 .
- the rack 1102 therefore does not move and remains stationary as the arm 1108 is moved backwards (e.g., in the direction 1702 ).
- the movement of the pawl 1606 in the direction 1704 can be passive, for example, based on a shape of the pawl 1606 and interaction with the teeth of the rack 1102 .
- the pawl 1606 can be spring loaded to enable disengagement and re-engagement of the pawl 1606 with the rack. In various embodiments, the pawl 1606 can be controlled, for example by a power source, to move in the direction 1704 .
- FIG. 18 illustrates the ratchet drive system 1600 re-engaging the rack 1102 .
- the arm 1108 is in close proximity to the power source 1106 .
- the pawl 1606 can move upwards in a direction 1802 to re-engage the rack 1102 .
- the ratchet drive system 1600 can be re-activated to a deliver a subsequent predetermined amount of the liquid drug.
- the movement of the pawl 1606 (e.g., in the direction 1802 ) can be passive movement or can be actively controlled.
- Example 1 is a ratchet drive system comprising a ratchet gear, a lead screw coupled to the ratchet gear, an end of the lead screw coupled to a plunger positioned in a drug container, a ratchet carrier positioned around the ratchet gear, a first pawl coupled to the ratchet carrier and a second pawl coupled to the ratchet carrier, the first and second pawls configured to selectively engage the ratchet gear, and a first carrier stop configured to restrict rotation of the ratchet carrier in a first direction.
- Example 2 is an extension of Example 1 or any other example disclosed herein, comprising a second carrier stop configured to restrict rotation of the ratchet carrier in a second, opposite direction.
- Example 4 is an extension of Example 3 or any other example disclosed herein, wherein the ratchet gear and the lead screw are configured to rotate in the first direction when the ratchet carrier is rotated in the first direction.
- Example 5 is an extension of Example 4 or any other example disclosed herein, wherein the lead screw is configured to move in a linear direction when the ratchet carrier is rotated in the first direction, the linear direction parallel to an axis of rotation of the ratchet carrier.
- Example 6 is an extension of Example 5 or any other example disclosed herein, wherein the lead screw is configured to move the plunger in the linear direction and further into the drug container when the ratchet carrier is rotated in the first direction.
- Example 7 is an extension of Example 6 or any other example disclosed herein, wherein the plunger is configured to expel a portion of a liquid drug stored in the drug container when moved in the linear direction.
- Example 8 is an extension of Example 7 or any other example disclosed herein, wherein a predetermined dose of the liquid drug is expelled from the drug container when the ratchet carrier is rotated in the first direction from an initial position corresponding to the second carrier stop to a final position corresponding to the first carrier stop.
- Example 9 is an extension of Example 8 or any other example disclosed herein, wherein the first and second carrier stops are displaced by approximately 180 degrees.
- Example 11 is an extension of Example 8 or any other example disclosed herein, wherein the first and second pawls are configured to disengage the ratchet gear when the ratchet carrier is rotated in the second direction, thereby decoupling the ratchet gear from the ratchet carrier.
- Example 12 is an extension of Example 11 or any other example disclosed herein, wherein the ratchet gear and the lead screw are configured to remain stationary when the ratchet gear is rotated in the second direction.
- Example 13 is an extension of Example 11 or any other example disclosed herein, wherein the ratchet carrier is rotated in the second direction to return to the initial position to reset the ratchet drive system.
- Example 14 is an extension of Example 13 or any other example disclosed herein, wherein the first and second pawls are configured to re-engage the ratchet gear when the ratchet drive system is reset.
- Example 15 is an extension of Example 13 or any other example disclosed herein, further comprising a power source for rotating the ratchet carrier.
- Example 16 is an extension of Example 51 or any other example disclosed herein, wherein the ratchet gear comprises gear teeth position around a perimeter of the ratchet carrier, wherein the ratchet drive system further comprises a gear coupled to the gear teeth of the ratchet carrier and coupled to the power source, wherein the power source rotates the ratchet carrier by rotating the gear.
- Example 17 is an extension of Example 16 or any other example disclosed herein, further comprising a controller, the controller configured to control operation of the power source and rotation of the ratchet carrier.
- Example 18 is an extension of Example 17 or any other example disclosed herein, wherein the first and second carrier stops each include a sensor configured to detect when the ratchet carrier is in the final position and the initial position, respectively.
- Example 20 is an extension of Example 18 or any other example disclosed herein, wherein the controller is configured to maintain a count of a number of predetermined doses of the liquid drug that have been delivered based on the signals transmitted by the sensors.
- Example 22 is a method comprising rotating a ratchet carrier in a first direction from an initial position to a final position, rotating a ratchet gear in the first direction based on rotating the ratchet carrier, rotating a lead screw in the first direction based on rotating the ratchet gear, moving the lead screw in a linear direction parallel to an axis of rotation of the lead screw based on rotating the lead screw, the lead screw coupled to a plunger positioned in a drug container holding a liquid drug, and moving the plunger in the linear direction further into the drug container based on moving the lead screw, thereby expelling a dose of the liquid drug from the drug container.
- Example 24 is an extension of Example 23 or any other example disclosed herein, further comprising detecting the final position of the ratchet carrier based on a sensor of the first carrier stop.
- Example 25 is an extension of Example 24 or any other example disclosed herein, further comprising maintaining a count of a number of doses of the liquid drug expelled based on detecting the final position of the ratchet carrier.
- Example 26 is an extension of Example 25 or any other example disclosed herein, further comprising rotating the ratchet gear in a second direction opposite the first direction from the final position to the initial position.
- Example 27 is an extension of Example 26 or any other example disclosed herein, further comprising decoupling the ratchet carrier from the ratchet gear prior to rotating the ratchet gear in the second direction, thereby preventing the ratchet gear and the lead screw from rotating in the second direction.
- Example 28 is an extension of Example 27 or any other example disclosed herein, further comprising restricting rotation of the ratchet carrier beyond the initial position based on a position of a second carrier stop.
- Example 29 is an extension of Example 28 or any other example disclosed herein, further comprising detecting the initial position of the ratchet carrier based on a sensor of the second carrier stop.
- Example 1 is a ratchet drive system, comprising a power source, an arm coupled to the power source, a pawl coupled to an end of the arm, a rack coupled to the arm through the pawl, and a plunger coupled to the end of the rack, the plunger positioned within a drug container storing a liquid drug.
- Example 2 is an extension of Example 1 or any other example disclosed herein, the power source configured to cause the arm to extend in a first direction, thereby moving the rack in the first direction.
- Example 3 is an extension of Example 2 or any other example disclosed herein, wherein the plunger is configured move in the first direction further into the drug container when the rack is moved in the first direction.
- Example 4 is an extension of Example 3 or any other example disclosed herein, wherein a portion of the liquid drug is expelled from the drug container when the plunger is moved in the first direction.
- Example 5 is an extension of Example 4 or any other example disclosed herein, wherein a predetermined dose of the liquid drug is expelled from the drug container when the arm is moved in the first direction from an initial position to a final position.
- Example 7 is an extension of Example 6 or any other example disclosed herein, wherein the pawl is configured to disengage the rack after the arm is in the final position.
- Example 9 is an extension of Example 8 or any other example disclosed herein, wherein the rack and the plunger are configured to remain stationary when the arm moves in the second direction.
- Example 10 is an extension of Example 9 or any other example disclosed herein, wherein the ratchet drive system is reset when the arm moves in the second direction to return to the initial position.
- Example 11 is an extension of Example 10 or any other example disclosed herein, wherein the pawl is configured to re-engage the rack when the ratchet drive system is reset.
- Example 12 is an extension of Example 11 or any other example disclosed herein, further comprising a controller for activating movement of the arm in the first direction and the second direction based on control of the power source.
- Example 13 is an extension of Example 12 or any other example disclosed herein, wherein the power source is a motor.
- Example 14 is an extension of Example 12 or any other example disclosed herein, wherein the power source is a linear actuator.
- Example 15 is an extension of Example 12 or any other example disclosed herein, wherein the controller is configured to maintain a count of a number of predetermined doses of the liquid drug that have been expelled based on the movement of the arm.
- Example 16 is an extension of Example 1 or any other example disclosed herein, wherein the drive system is part of an on-body delivery system (OBDS).
- OBDS on-body delivery system
- Example 18 is an extension of Example 17 or any other example disclosed herein, further comprising detecting the final position of the arm.
- Example 19 is an extension of Example 18 or any other example disclosed herein, further comprising maintaining a count of a number of doses of the liquid drug expelled based on detecting the final position of the arm.
- Example 20 is an extension of Example 19 or any other example disclosed herein, further comprising coupling the arm to the rack with a pawl.
- Example 21 is an extension of Example 20 or any other example disclosed herein, further comprising moving the pawl to decouple the arm from the rack after the arm is extended to its final position.
- Example 22 is an extension of Example 21 or any other example disclosed herein, further comprising rotating the pawl to decouple the arm from the rack after the arm is extended to its final position.
- Example 23 is an extension of Example 21 or any other example disclosed herein, further comprising moving the pawl in a direction away from the rack to decouple the arm from the rack after the arm is extended to its final position.
- Example 25 is an extension of Example 24 or any other example disclosed herein, further comprising restricting movement of the rack and the plunger in the second direction.
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Fluid Mechanics (AREA)
- Dermatology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
- This application is a continuation of U.S. patent application Ser. No. 15/809,491, filed Nov. 10, 2017, which claims the benefit of U.S. Provisional Application No. 62/420,382, filed Nov. 10, 2016, and U.S. Provisional Application No. 62/439,822, filed Dec. 28, 2016, each of which is incorporated herein by reference in its entirety.
- Embodiments generally relate to medication delivery. More particularly, embodiments relate to drive systems for drug delivery devices.
- An on-body delivery system (OBDS) can be used to deliver drug dosages to a user over time. During a control system failure of the OBDS, there can be a risk of delivering too much of a drug to the user resulting in a possible drug overdose condition. Accordingly, there is a need for an OBDS having a drive system for delivering a drug to a user that can prevent delivery of too much of a drug to the user during a system failure.
-
FIG. 1 illustrates a first exemplary ratchet drive system. -
FIG. 2 illustrates the first ratchet drive system in an idle state. -
FIG. 3 illustrates the first ratchet drive system during delivery of a drug. -
FIG. 4 illustrates the first ratchet drive system after delivery of the drug. -
FIG. 5 illustrates the first ratchet drive system during a first phase of reset. -
FIG. 6 illustrates the first ratchet drive system during a second phase of reset. -
FIG. 7 illustrates the first ratchet drive system in relation to a controller. -
FIG. 8 illustrates a second exemplary ratchet drive system. -
FIG. 9 illustrates the second ratchet drive system after delivery of a drug. -
FIG. 10 illustrates the first ratchet drive system in relation to a drug container. -
FIG. 11 illustrates a third exemplary ratchet drive system. -
FIG. 12 illustrates the third ratchet drive system in an idle state. -
FIG. 13 illustrates the third ratchet drive system during delivery of a drug. -
FIG. 14 illustrates the third ratchet drive system after delivery of the drug during a first phase of reset. -
FIG. 15 illustrates the third ratchet drive system during a second phase of reset. -
FIG. 16 illustrates a fourth ratchet drive system during delivery of a drug. -
FIG. 17 illustrates the fourth ratchet drive system after delivery of the drug during a first phase of reset. -
FIG. 18 illustrates the fourth ratchet drive system during a second phase of reset. -
FIG. 19 illustrates the first ratchet drive system in relation to a power source. - This disclosure presents various systems, components, and methods related to a drug delivery device. Each of the systems, components, and methods disclosed herein provides one or more advantages over conventional systems, components, and methods.
- Various embodiments provide for drug delivery using ratchet-based drive systems. The ratchet-based drive systems restrict angular movement and/or linear movement of components that cause a plunger to expel a liquid drug from a drug container. Movement of the components can be restricted to expel only a predetermined or desired amount of the liquid drug. In the case that control of the drive system is lost or fails, the maximum amount of drug that could be delivered is limited to a known amount, thereby reducing the likelihood of an overdose. The predetermined amount of the liquid drug expelled can correspond to any portion of the liquid drug including a single dose of the liquid drug or a portion thereof.
-
FIG. 1 illustrates a first exemplaryratchet drive system 100. Theratchet drive system 100 can be incorporated as part of an on-body delivery system (OBDS) as described herein. Theratchet drive system 100 can include alead screw 102, aratchet gear 104, aratchet carrier 106, a first pawl 108-1, a second pawl 108-2, a first carrier stop 110-1, and a second carrier stop 110-2. As shown inFIG. 1 , thelead screw 102 can be coupled to theratchet gear 104 and can be positioned through the ratchet gear 104 (e.g., through a center hole of the ratchet gear 104). Thelead screw 102 can include threads that engage theratchet gear 104. Thelead screw 102 can also be positioned through the ratchet carrier (e.g., through a center hole of the ratchet carrier 106). An end of thelead screw 102 that extends beyond theratchet carrier 106 can be coupled to a plunger positioned within a drug cartridge (not shown inFIG. 1 ). Theratchet drive system 100 can be operated such that rotation of thelead screw 102 can cause the plunger to be advanced, thereby expelling a portion of a liquid drug stored in the drug cartridge. Theratchet drive system 100 can prevent over-delivery (e.g., overdose) of the liquid drug (e.g., during system failure of the OBDS incorporating the ratchet drive system 100) to ensure safe delivery of the liquid drug and operation of the OBDS as described herein. - The first and second pawls 108-1 and 108-2 can be coupled to the
ratchet carrier 106. As shown inFIG. 1 , the first and second pawls 108-1 and 108-2 can be positioned to engage the ratchet gear 104 (e.g., the outer teeth of the ratchet gear 104). To expel a portion of the liquid drug from the drug container, theratchet carrier 104 can be rotated (e.g., about a central axis ofrotation 114 in a clockwise direction with respect to the depiction of theratchet drive system 100 inFIG. 1 ). Theratchet carrier 106 can be rotated by an amount corresponding to the position of the second carrier stop 110-2. That is, theratchet carrier 106 can be rotated such that an extension orprotrusion 112 of theratchet carrier 106 moves from the first carrier stop 110-1 to the second carrier stop 110-2. Theextension 112 of theratchet carrier 106 can be stopped by or can be positioned adjacent to the second carrier stop 110-2 when a desired portion (e.g., a dose or portion thereof) of the liquid drug has been expelled from the drug container. The first and second carrier stops 110-1 and 110-2 can be coupled to a portion of the OBDS incorporating theratchet drive system 100. - When the
ratchet carrier 106 is rotated from the first carrier stop 110-1 toward the second carrier stop 110-2, theratchet gear 104 can be caused to similarly rotate based on the engagement of the first and second pawls 108-1 and 108-2. That is, the first and second pawls 108-1 and 108-2 can couple theratchet carrier 106 to theratchet gear 104. The rotation of theratchet gear 104 can cause thelead screw 102 to also rotate. Theratchet gear 104 can be tightly coupled to thelead screw 102 to ensure that rotation of theratchet gear 104 results in rotation of thelead screw 102. Rotation of thelead screw 102 can cause thelead screw 102 to advance in adirection 116 that can be parallel to thecentral axis 114. This movement of thelead screw 102 can cause the plunger to move further into the drug container, which can cause a portion of the liquid drug stored therein to be expelled. The linear displacement of thelead screw 102 in thedirection 116 caused by rotation of theratchet carrier 106 and theratchet gear 104 can be based on a thread pitch of thelead screw 102 which can be adjusted for particular applications and drug dosages. The amount of liquid drug expelled can correspond to a predetermined or desired amount of the liquid drug stored in the drug container. In various embodiments, any portion of the liquid drug can be expelled including, for example, a single dose of the liquid drug or a portion thereof. Accordingly, in various embodiments, movement of theratchet carrier 106 from the first carrier stop 110-1 to the second carrier stop 110-2 can cause a single dose of the liquid drug to be expelled from the drug container for delivery to a patient or user. - After the
ratchet carrier 106 has been moved to a position corresponding to the second carrier stop 110-2, theratchet carrier 106 can be rotated back to a position corresponding to the first carrier stop 110-2 (e.g., as shown inFIG. 1 ). As shown inFIG. 1 , theratchet drive system 100 can be in an initial or reset state awaiting activation so as to rotate theratchet carrier 106 toward the second carrier stop 110-2 for delivery of a portion of the liquid drug. Prior to rotating theratchet carrier 106 back to a position corresponding the first carrier stop 110-1 as shown inFIG. 1 , the first and second pawls 108-1 and 108-2 can be disengaged from theratchet gear 104. Releasing the first and second pawls 108-1 and 108-2 from theratchet gear 104 can prevent theratchet gear 104 from rotating when theratchet carrier 106 is rotated back toward the first carrier stop 110-1. As a result, the position of thelead screw 102 is maintained (e.g., thelead screw 102 is not advanced in thedirection 116 when theratchet carrier 106 is rotated back toward the first carrier stop 110-1). The first and second pawls 108-1 and 108-2 can then re-engage theratchet gear 104 after theratchet carrier 104 is moved back to the position shown inFIG. 1 . Theratchet drive system 100 can then await a subsequent activation (e.g., an instruction to rotate theratchet carrier 106 toward the second carrier stop 110-2) for a next cycle of drug delivery. The first and second pawls 108-1 and 108-2 can be coupled to a control system that can rotate or otherwise adjust the position of the first and second pawls 108-1 and 108-2 to engage and disengage theratchet gear 104 as desired. - In various embodiments, the
ratchet carrier 106 can be positioned around theratchet gear 104. Theratchet gear 104 can be positioned within an opening of theratchet carrier 106. In various embodiments, theratchet drive system 100 can include a single pawl or more than two pawls. - The operation of the
ratchet drive system 100 can prevent over-delivery of the liquid drug that theratchet drive system 100 can be used to expel from the drug container. The second carrier stop 110-2 can prevent thelead screw 102 from rotating more than a desired amount, by restricting further rotation of theratchet carrier 106, thereby restricting further advancement of the plunger coupled to thelead screw 102. As a result, further delivery of the liquid drug is prevented. During system failure of the OBDS that incorporates the ratchet drive system 100 (e.g., a power failure), the risk of over-delivery of the liquid drug is mitigated by the restricted movement of thelead screw 102. Precise dosing of the liquid drug can also be provided by theratchet drive system 100. - The first and second carrier stops 110-1 and 110-2 can be displaced by any amount. As shown in
FIG. 1 , the first and second carrier stops 110-1 and 110-2 are displaced by approximately 180 degrees but are not so limited. The displacement of the first and second carrier stops 110-1 and 110-2 can correspond to delivery of a predetermined or desired amount of the liquid drug when theratchet carrier 106 is rotated from the first carrier stop 110-1 to the second carrier stop 110-2 but is not so limited. In various embodiments, the predetermined amount of the liquid drug can correspond to a single dose of the liquid drug or a portion thereof. - The
ratchet carrier 106 can be coupled to a power source to effectuate rotation of theratchet carrier 106. The power source can comprise a motor but is not so limited. The power source can comprise a mechanical system or an electromechanical system. The power source can cause theratchet carrier 106 to be rotated toward the second carrier stop 110-1 based upon an activation signal provided by the OBDS (e.g., a controller). The activation can be automatically provided or can be generated responsive to a user input. The power source can cause theratchet carrier 106 to rotate back toward the first carrier stop 110-1 immediately after providing the dosage of the liquid drug or after a predetermined delay. - The OBDS in which the
ratchet drive system 100 can be incorporated can be any type of wearable drug delivery system such as, for example, the OmniPod® (Insulet Corporation, Billerica, Mass.) insulin delivery device and/or a drug delivery device such as those described in U.S. Pat. Nos. 7,303,549, 7,137,964, or U.S. Pat. No. 6,740,059, each of which is incorporated herein by reference in its entirety. -
FIG. 2 illustrates a second view of theratchet drive system 100 depicted inFIG. 1 .FIG. 1 can represent an isometric view of theratchet drive system 100.FIG. 2 can represent a corresponding front view of theratchet drive system 100. As shown inFIG. 2 , theextension 112 can be positioned adjacent to the first carrier stop 110-1 and the first and second pawls 108-1 and 108-2 can be engaged with theratchet gear 104.FIG. 2 can represent theratchet drive system 100 in an initial or idle state prior to being activated to rotate theratchet carrier 106. Further, theratchet carrier 106 can be considered to be in an initial position as depicted inFIG. 2 . -
FIG. 3 illustrates a front view of theratchet drive system 100 during delivery of the liquid drug. As shown inFIG. 3 , theratchet carrier 106 is rotated in a direction 302 (e.g., a clockwise direction relative to the depiction of theratchet drive system 100 inFIG. 3 ). As shown, theextension 112 is moving toward the second carrier stop 110-2. The first and second pawls 108-1 and 108-2, theratchet gear 104, and thelead screw 102 each correspondingly rotate in thedirection 302. Further, thelead screw 102 is linearly displaced in a direction parallel to thecentral axis 114. -
FIG. 4 illustrates a front view of theratchet drive system 100 after delivery of the liquid drug. As shown inFIG. 4 , theratchet carrier 106 has been rotated such that theextension 112 is positioned adjacent to the second carrier stop 110-2. The second carrier stop 110-2 can prevent theratchet carrier 106 from rotating any further, thereby preventing further linear displacement of thelead screw 102. The rotation of theratchet carrier 106 from the first carrier stop 110-1 to the second carrier stop 110-2 can correspond to expelling and delivering a desired amount or portion of the liquid drug. Theratchet carrier 106 can be considered to be in a final position as depicted inFIG. 4 . -
FIG. 5 illustrates a front view of theratchet drive system 100 during an initial resetting of theratchet drive system 100. As shown inFIG. 5 , the first and second pawls 108-1 and 108-2 are disengaged from theratchet gear 104. Accordingly, when theratchet carrier 106 is rotated back toward the first carrier stop 110-1, theratchet gear 104 and thelead screw 102 will remain stationary. As a result, none of the liquid drug will be expelled from the drug container when theratchet carrier 106 is rotated back towards the first carrier stop 110-1. -
FIG. 6 illustrates a front view of theratchet drive system 100 during further resetting of theratchet drive system 100. As shown inFIG. 6 , theratchet carrier 106 is rotated in a direction 602 (e.g., a counter-clockwise direction relative to the depiction of theratchet drive system 100 inFIG. 6 ). As shown, theextension 112 is moved toward the first carrier stop 110-1 and is shown positioned adjacent to the first carrier stop 110-1 (e.g., corresponding to the initial position of the ratchet carrier 106). The first and second pawls 108-1 and 108-2 are similarly rotated in thedirection 602. After theratchet carrier 106 is fully rotated back to the initial position (e.g., to a reset or the initial position), the first and second pawls 108-1 and 108-2 can re-engage the ratchet gear 104 (e.g., as depicted inFIG. 2 ). Theratchet drive system 100 can then remain in the reset or idle state until being activated again to repeat delivery and the reset cycle as described herein. As with the second carrier stop 110-2, the first carrier stop 110-1 can also restrict further rotation of theratchet carrier 106. -
FIG. 7 illustrates theratchet drive system 100 with anexemplary controller 702. Thecontroller 702 can be coupled to the first carrier stop 110-1, the second carrier stop 110-1, and any other component of theratchet drive system 100 such as theratchet carrier 106. Thecontroller 702 can direct operation of theratchet drive system 100. The first and second carrier stops 110-1 and 110-2 can each include one or more sensors that can inform thecontroller 702 as to the position of theratchet carrier 106. For example, the first and second carrier stops 110-1 and 110-2 can each include a sensor that can inform thecontroller 702 when theextension 112 is touching or in close proximity to one of the first and second carrier stops 110-1 and 110-2. Positional information of theratchet carrier 106 can also be provided to thecontroller 702 from rotation of theratchet carrier 106. Thecontroller 702 can be coupled to the power source of theratchet drive system 100 to direct the power source to rotate theratchet carrier 106 in a desired direction based on, for example, positional information of theratchet carrier 106 provided by at least the first and second carrier stops 110-1 and 110-2. - During delivery of a portion of the liquid drug, the sensor in the second carrier stop 110-2 can send a signal to the
controller 702 indicating the position of the extension 112 (e.g., when the extension touches or is adjacent to the second carrier stop 110-2). Thecontroller 702 can adjust or stop the rotation of the ratchet carrier 106 (e.g., in the direction 302) based on signals received from the second carrier stop 110-2. Further, signals from the second carrier stop 110-2 can allow thecontroller 702 to maintain a count of the number of times theextension 112 has reached the second carrier stop 110-2. In this way, a count of the number of times the drug is delivered or expelled can be maintained, along with a count of the remaining number of times the drug can be expelled. In various embodiments, when the portion expelled corresponds to a desired dose of the liquid drug or portion thereof, a count of the number of doses of drug delivered or expelled can be maintained, along with a count of remaining doses. - The sensor in the first carrier stop 110-1 can similarly send a signal to the
controller 702 indicating the position of the extension 112 (e.g., when the extension touches or is adjacent to the first carrier stop 110-1). Thecontroller 702 can adjust or stop the rotation of the ratchet carrier 106 (e.g., in the direction 602) based on signals received from the first carrier stop 110-1. Signals from the first carrier stop 110-1 can also be used to maintain a count of the number of times the liquid drug is delivered or expelled and a count of how many more times the drug can be expelled before the drug container is substantially empty. As described above, in various embodiments, when the portion expelled corresponds to a desired dose of the liquid drug or portion thereof, the signals from the first carrier stop 110-1 can enable a count of the number of doses of drug delivered or expelled can be maintained, along with a count of remaining doses. -
FIG. 8 illustrates a second exemplaryratchet drive system 800. Theratchet drive system 800 can include substantially the same components of theratchet drive system 100 and can operate in a substantially similar manner as theratchet drive system 100. Theratchet drive system 800 can include a single carrier stop 802 (as opposed to two carrier stops as included with the ratchet drive system 100). Theratchet drive system 800 as shown inFIG. 8 can be in an initial position or idle state prior to being activated to deliver a portion of the liquid drug. When activated or instructed to deliver a portion of the liquid drug, theratchet carrier 106 can rotate in a clockwise direction (relative to the depiction of theratchet drive system 800 inFIG. 8 ). Theextension 112 can rotate until reaching the other side of thecarrier stop 802. In doing so, theratchet gear 104 and thelead screw 102 can similarly rotate. A desired amount of drug can be expelled from the drug container based on this rotation of theratchet carrier 106. - The
carrier stop 802 can include one or more sensors for detecting a position of theratchet carrier 106. As with theratchet drive system 100, theratchet drive system 800 can further include a controller for directing operation of theratchet drive system 800 based on signals received from one or more sensors of thecarrier stop 802. Like theratchet drive system 100, theratchet drive system 800 can be coupled to a power source (e.g., a motor) to provide an input for rotating theratchet carrier 106. -
FIG. 9 illustrates theratchet drive system 800 after delivering a portion of the liquid drug. As shown inFIG. 9 , theratchet carrier 106 has rotated such that theextension 112 is positioned on the other side of the carrier stop 802 (as compared to the position of theextension 112 as shown inFIG. 8 ). The first and second pawls 108-1 and 108-2 and theratchet gear 104 have similarly rotated. Theratchet carrier 106 has rotated just under 360 degrees. For a motor power source, the implementation of theratchet drive system 800 with thesingle carrier stop 802 can reduce the number of motor cycles used to deliver the same advancement of thelead screw 102. -
FIG. 10 illustrates a side view of theratchet drive system 100 in relationship to adrug container 1002. For simplicity, the first and second carrier stops 110-2 and 110-2 are not shown. As shown inFIG. 10 , thelead screw 102 extends through and beyond the ratchet carrier 106 (e.g., through a central hole or opening of the ratchet carrier 106). Theratchet carrier 106 can be coupled to or positioned adjacent to thedrug container 1002. Thedrug container 1002 can include an area orreservoir 1004 for holding a liquid drug as described herein. Thedrug container 1002 can further include aport 1006 through which the liquid drug stored in thereservoir 1004 can be expelled out of thedrug container 1002. - The
lead screw 102 can be coupled to aplunger 1008. Theplunger 1008 can define a boundary of thereservoir 1004. As described herein, when theratchet carrier 106 is rotated in a first direction to initiate drug delivery, thelead screw 102 can rotate about thecentral axis 114. As a result, thelead screw 102 can move in thedirection 116 and can push on theplunger 1008 to drive theplunger 1008 in thedirection 116 as well. The movement of theplunger 1008 in thedirection 116 can expel a portion of the liquid drug stored in thereservoir 1004 from the drug container 1002 (e.g., through theexit port 1006 for subsequent delivery to a patient). - The
ratchet drive system 100 and additional components depicted inFIG. 10 can be incorporated into an OBDS as described herein. Theratchet drive system 800 can be similarly coupled to the additional components depicted inFIG. 10 as will be understood by a person of ordinary skill in the art. As described herein, theratchet drive systems - For example, if the power source for the
ratchet drive system 100 suddenly and/or catastrophically failed at any time (e.g., during delivery of a dose and/or movement ofratchet carrier 106 toward the second carrier stop 110-2), then the second carrier stop 110-2 can restrict the angular movement of theratchet carrier 106. As a result, delivery of any further drug can be prevented. In particular, the second carrier stop 110-2 can block movement of theratchet carrier 106 that could be caused by any force such as inertia or gravity that may attempt to rotate theratchet carrier 106 any further. As described herein, the maximum angular movement of theratchet carrier 106 can be restricted by a desired amount such that the angular displacement corresponds to a desired drug delivery, ensuring that drug delivery can be limited to a desired amount in a runaway operation condition. In various embodiments, as described above in relation to the other disclosed ratchet drive systems, any portion of the stored liquid drug can be delivered during each cycle of movement including, for example, a single desired dose of the liquid drug or a portion thereof. Theratchet drive system 800 provides the same prevention of overdose during such conditions by the carrier stop 802 similarly restricting movement of theratchet carrier 106. -
FIG. 19 illustrates theratchet drive system 100 with anexemplary power source 1906. Thepower source 1906 can be a motor. Themotor 1906 can interface with theratchet drive system 100 as shown to facilitate movement of theratchet carrier 106 as described herein. - In various embodiments, as shown in
FIG. 19 , theratchet carrier 106 can includegear teeth 1902. Thegear teeth 1902 can be positioned along a perimeter of theratchet carrier 106 and can project from theratchet carrier 106. Agear 1904 can be coupled to theratchet carrier 106 as shown. In various embodiments, teeth of thegear 1904 can interface with thegear teeth 1902 of theratchet carrier 106. Thegear 1904 can be coupled to themotor 1906. Themotor 1906 can rotate theratchet gear 1906 as desired and as described herein by rotation of thegear 1904 as will be understood by a person of ordinary skill in the art. Accordingly, themotor 1906 can control delivery of the liquid drug by rotating theratchet carrier 106 as desired and can rotate theratchet carrier 106 back to an idle state after delivery. Themotor 1906 can initiate rotation automatically or based on user input. - In various embodiments, the
ratchet drive systems ratchet carrier 106 as will be appreciated by one skilled in the art. -
FIG. 11 illustrates a third exemplaryratchet drive system 1100. As with theratchet drive systems ratchet drive system 1100 can be used in an OBDS as described herein. Theratchet drive system 1100 can include arack 1102, aplunger 1104, apower source 1106, anarm 1108, apawl 1110, and adrug container 1112. As shown inFIG. 11 , therack 1102 can be coupled to theplunger 1104. Theplunger 1104 can be positioned within thedrug container 1112. Thepower source 1106 can be, for example, a motor or a linear actuator. Thepower source 1106 can be coupled to thearm 1108. Thepawl 1110 can be coupled to thearm 1108. - The
ratchet drive system 1100 can be operated such that linear movement of the arm 1108 (e.g., in a direction away from the power source 1106) can drive theplunger 1104 further into thedrug container 1112, thereby expelling a portion of a liquid drug stored in the drug cartridge. Like theratchet drive systems ratchet drive system 1100 can prevent over-delivery (e.g., overdose) of the liquid drug (e.g., during system failure of the OBDS incorporating the ratchet drive system 1100) to ensure safe delivery of the liquid drug and operation of the OBDS as described herein. -
FIG. 11 can represent theratchet drive system 1100 in an idle state prior to activation. When activated, theratchet drive system 1100 can operate to deliver a desired amount of the stored liquid drug to a user. Specifically, when activated, thepower source 1106 can cause thearm 1108 to extend (e.g., in a direction away from the power source 1106). When thearm 1108 extends, therack 1102 can be caused to move forward (e.g., in the same direction that the arm 108 extends) by the coupling of thearm 1108 to therack 1102 by thepawl 1110. As a result, theplunger 1104 is driven further into the drug container, expelling a portion of the stored liquid drug. - The
arm 1108 can be sized and controlled to extend a desired amount away from thepower source 1106 when theratchet drive system 1100 is activated. By limiting the amount by which thearm 1108 can extend (e.g., to a maximum extension amount), the movement of theplunger 1104 can likewise be limited. In this way, over-delivery can be mitigated by limiting the amount of liquid drug that can be expelled during each activation of theratchet drive system 1100. After thearm 1108 is fully extended, thearm 1108 can be operated to move back to its original position (e.g., retracted back toward the power source 1106). The position of therack 1102 can be maintained by having thepawl 1110 disengage therack 1102 prior to thearm 1108 moving in a direction back toward thepower source 1108. - The
ratchet drive system 1100 can be used with the same OBDSs described in relation to theratchet drive systems ratchet drive systems ratchet drive system 1100 to direct operation of thepower source 1106 and therefore delivery of the liquid drug. The controller can direct operation of thepower source 1106 based on, for example, positional information of theplunger 1104, therack 1102, and/or thearm 1108. The controller can track delivery of the liquid drug to determine a number of times a portion of the drug is delivered and/or an amount of liquid drug remaining as described herein, for example based on the movement of thearm 1108. Thedrug container 1112, like thedrug container 1002, can include a port for the liquid drug (not shown inFIG. 11 ). -
FIG. 12 illustrates a second view of theratchet drive system 1100 depicted inFIG. 11 .FIG. 11 can represent an isometric view of theratchet drive system 1100.FIG. 12 can represent a corresponding side view of theratchet drive system 1100. As shown inFIG. 12 , thepawl 1110 couples thearm 1108 to therack 1102. Thedrug container 1112 includes areservoir 1202 for storing the liquid drug. Thereservoir 1202 can be defined in part by theplunger 1104 and an end of the drug container (opposite to theplunger 1104; not shown inFIG. 12 ). The end of thedrug container 1112 can include a port or other opening allowing the liquid drug stored in thereservoir 1202 to be expelled as theplunger 1104 is advanced toward the end of thedrug container 1112. -
FIG. 13 illustrates theratchet drive system 1100 during delivery of the liquid drug. As shown inFIG. 13 , thearm 1108 extends in adirection 1302. As a result, therack 1102 andplunger 1104 are advanced in adirection 1304 as shown. The advancement of theplunger 1104 further into thedrug container 1112 can cause a portion of the liquid drug stored in thereservoir 1202 to be expelled from thedrug container 1112. Thearm 1108 can be sized such that extension of thearm 1108 in thedirection 1302 corresponds to a desired amount of the liquid drug being expelled (e.g., a single dose or a portion thereof). As described herein, the length of thearm 1108 can be limited such that only a desired amount of the liquid drug is expelled by moving therack 1102 and theplunger 1104 by the amount thearm 1108 is extended. Runaway operation and over-delivery of the liquid drug can therefore be avoided in case of a system failure (e.g., power loss) of the OBDS in which theratchet drive system 1100 is incorporated since further movement of therack 1102 by thearm 1108 is restricted. - After the
arm 1108 is extended by the set amount, thearm 1108 and therack 1102 can come to a rest. The controller can track the movement of thearm 1008 and can maintain a count of the number of times thearm 1108 is extended to expel the liquid drug. The amount thearm 1108 is extended can correspond to any desired amount of drug to be delivered to a user including, for example, a single dose of the liquid drug, or a portion thereof. -
FIG. 14 illustrates theratchet drive system 1100 initiating a return to its initial or idle state. As shown inFIG. 14 , thearm 1108 is a moved in adirection 1402 back toward thepower source 1106. Thepawl 1110 is shaped so as to rotate in adirection 1404 as thearm 1108 is moved in thedirection 1402. As a result, thepawl 1110 is disengaged from therack 1102. Therack 1102 therefore does not move and remains stationary as thearm 1108 is moved backwards (e.g., in the direction 1402). In various embodiments, thepawl 1110 can be controlled to rotate in thedirection 1404 to facilitate disengagement from therack 1102. Thearm 1108 can be retracted back to an original position corresponding to the position of thearm 1108 prior to activation. -
FIG. 15 illustrates theratchet drive system 1100 re-engaging therack 1102. As shown inFIG. 15 , thearm 1108 is in close proximity to thepower source 1106. When thearm 1108 stops moving, thepawl 1110 rotates in adirection 1502 to re-engage therack 1102. Once thepawl 1110 re-engages therack 1102, theratchet drive system 1110 can be re-activated to a deliver a subsequent amount of the liquid drug. - In various embodiments, the stroke of the
arm 1108 can be greater than a length of one tooth on of therack 1102 so as to provide clearance for thepawl 1110 to rotate as described herein without hitting a tooth of therack 1102. In various embodiments, the rotational movement of thepawl 1110 and/or the linear movement of thepawl 1110 can be passive movements, as the angle of therack 1102 can push thepawl 1110 out of the way. In such embodiments, thepawl 1110 can be spring loaded, for example, and biased to be in the engaged position as shown inFIG. 15 . As described above, in various other embodiments, thepawl 1110 can be actively rotated as desired for retraction, using a separate power source for example. - As described herein, the
ratchet drive system 1100 can also prevent overdose situations that can occur with conventional drive systems for drug delivery devices by restricting linear movement and using multiple actuations cycles to deliver one or more doses of the liquid drug. For example, if thepower source 1108 suddenly and/or catastrophically fails at any time (e.g., during delivery of a dose and/or when thearm 1108 is being extended), then the length of the arm 1108 (e.g., maximum extension of the arm 1108) can restrict the amount by which therack 1102 and theplunger 1104 can move. As a result, delivery of any further drug can be prevented. -
FIG. 16 illustrates a fourth exemplaryratchet drive system 1600. Theratchet drive system 1600 can be a variation of theratchet drive system 1100. As with theratchet drive systems ratchet drive system 1600 can be used in an OBDS as described herein and can provide the same benefits as theratchet drive system 1600. Theratchet drive system 1600 can include therack 1102, theplunger 1104, thepower source 1106, thearm 1108, apawl 1606, and thedrug container 1112. Theratchet drive system 1600 can operate in a substantially similar manner as theratchet system 1100 with the exceptions described herein. - As shown in
FIG. 16 , thepawl 1606 can be coupled to thearm 1108. As opposed to rotating like thepawl 1110, thepawl 1606 can be coupled to thearm 1108 and arranged to move up and down (e.g., towards and away from the rack 1102) to engage and disengage from therack 1102 as described further herein. -
FIG. 16 illustrates theratchet drive system 1600 during delivery of the liquid drug. As shown inFIG. 16 , thearm 1108 extends in adirection 1602 and thepawl 1606 is engaged with therack 1102. As a result, therack 1102 and theplunger 1104 are advanced in adirection 1604 as shown. The advancement of theplunger 1104 further into thedrug container 1112 can cause a portion of the liquid drug stored in thereservoir 1202 to be expelled from thedrug container 1112 as described above in relation to theratchet drive system 1100. Once thearm 1108 is extended by a desired or predetermined amount, thearm 1108 and therack 1102 can come to rest. -
FIG. 17 illustrates theratchet drive system 1600 initiating a return to its initial or idle state. As shown inFIG. 17 , thearm 1108 is moved in adirection 1702 back toward thepower source 1106. Thepawl 1606 can move downward in adirection 1704 as thearm 1108 is moved in thedirection 1702. As a result, thepawl 1606 is disengaged from therack 1102. Therack 1102 therefore does not move and remains stationary as thearm 1108 is moved backwards (e.g., in the direction 1702). In various embodiments, the movement of thepawl 1606 in thedirection 1704 can be passive, for example, based on a shape of thepawl 1606 and interaction with the teeth of therack 1102. In various embodiments, thepawl 1606 can be spring loaded to enable disengagement and re-engagement of thepawl 1606 with the rack. In various embodiments, thepawl 1606 can be controlled, for example by a power source, to move in thedirection 1704. -
FIG. 18 illustrates theratchet drive system 1600 re-engaging therack 1102. As shown inFIG. 18 , thearm 1108 is in close proximity to thepower source 1106. When thearm 1108 stops moving, thepawl 1606 can move upwards in adirection 1802 to re-engage therack 1102. Once thepawl 1606 re-engages therack 1102, theratchet drive system 1600 can be re-activated to a deliver a subsequent predetermined amount of the liquid drug. As described above, the movement of the pawl 1606 (e.g., in the direction 1802) can be passive movement or can be actively controlled. - The following examples pertain to additional embodiments:
- Example 1 is a ratchet drive system comprising a ratchet gear, a lead screw coupled to the ratchet gear, an end of the lead screw coupled to a plunger positioned in a drug container, a ratchet carrier positioned around the ratchet gear, a first pawl coupled to the ratchet carrier and a second pawl coupled to the ratchet carrier, the first and second pawls configured to selectively engage the ratchet gear, and a first carrier stop configured to restrict rotation of the ratchet carrier in a first direction.
- Example 2 is an extension of Example 1 or any other example disclosed herein, comprising a second carrier stop configured to restrict rotation of the ratchet carrier in a second, opposite direction.
- Example 3 is an extension of Example 2 or any other example disclosed herein, wherein the first and second pawls are configured to engage the ratchet gear when the ratchet carrier is rotated in the first direction, thereby coupling the ratchet carrier to the ratchet gear.
- Example 4 is an extension of Example 3 or any other example disclosed herein, wherein the ratchet gear and the lead screw are configured to rotate in the first direction when the ratchet carrier is rotated in the first direction.
- Example 5 is an extension of Example 4 or any other example disclosed herein, wherein the lead screw is configured to move in a linear direction when the ratchet carrier is rotated in the first direction, the linear direction parallel to an axis of rotation of the ratchet carrier.
- Example 6 is an extension of Example 5 or any other example disclosed herein, wherein the lead screw is configured to move the plunger in the linear direction and further into the drug container when the ratchet carrier is rotated in the first direction.
- Example 7 is an extension of Example 6 or any other example disclosed herein, wherein the plunger is configured to expel a portion of a liquid drug stored in the drug container when moved in the linear direction.
- Example 8 is an extension of Example 7 or any other example disclosed herein, wherein a predetermined dose of the liquid drug is expelled from the drug container when the ratchet carrier is rotated in the first direction from an initial position corresponding to the second carrier stop to a final position corresponding to the first carrier stop.
- Example 9 is an extension of Example 8 or any other example disclosed herein, wherein the first and second carrier stops are displaced by approximately 180 degrees.
- Example 10 is an extension of Example 8 or any other example disclosed herein, wherein the first carrier stop is configured to prevent the ratchet carrier from rotating further in the first direction.
- Example 11 is an extension of Example 8 or any other example disclosed herein, wherein the first and second pawls are configured to disengage the ratchet gear when the ratchet carrier is rotated in the second direction, thereby decoupling the ratchet gear from the ratchet carrier.
- Example 12 is an extension of Example 11 or any other example disclosed herein, wherein the ratchet gear and the lead screw are configured to remain stationary when the ratchet gear is rotated in the second direction.
- Example 13 is an extension of Example 11 or any other example disclosed herein, wherein the ratchet carrier is rotated in the second direction to return to the initial position to reset the ratchet drive system.
- Example 14 is an extension of Example 13 or any other example disclosed herein, wherein the first and second pawls are configured to re-engage the ratchet gear when the ratchet drive system is reset.
- Example 15 is an extension of Example 13 or any other example disclosed herein, further comprising a power source for rotating the ratchet carrier.
- Example 16 is an extension of Example 51 or any other example disclosed herein, wherein the ratchet gear comprises gear teeth position around a perimeter of the ratchet carrier, wherein the ratchet drive system further comprises a gear coupled to the gear teeth of the ratchet carrier and coupled to the power source, wherein the power source rotates the ratchet carrier by rotating the gear.
- Example 17 is an extension of Example 16 or any other example disclosed herein, further comprising a controller, the controller configured to control operation of the power source and rotation of the ratchet carrier.
- Example 18 is an extension of Example 17 or any other example disclosed herein, wherein the first and second carrier stops each include a sensor configured to detect when the ratchet carrier is in the final position and the initial position, respectively.
- Example 19 is an extension of Example 18 or any other example disclosed herein, wherein each sensor is configured to transmit a signal to the controller to indicate at least one of the final position and the initial position of the ratchet carrier.
- Example 20 is an extension of Example 18 or any other example disclosed herein, wherein the controller is configured to maintain a count of a number of predetermined doses of the liquid drug that have been delivered based on the signals transmitted by the sensors.
- Example 21 is an extension of Example 1 or any other example disclosed herein, wherein the drive system is part of an on-body delivery system (OBDS).
- Example 22 is a method comprising rotating a ratchet carrier in a first direction from an initial position to a final position, rotating a ratchet gear in the first direction based on rotating the ratchet carrier, rotating a lead screw in the first direction based on rotating the ratchet gear, moving the lead screw in a linear direction parallel to an axis of rotation of the lead screw based on rotating the lead screw, the lead screw coupled to a plunger positioned in a drug container holding a liquid drug, and moving the plunger in the linear direction further into the drug container based on moving the lead screw, thereby expelling a dose of the liquid drug from the drug container.
- Example 23 is an extension of Example 22 or any other example disclosed herein, further comprising restricting rotation of the ratchet carrier beyond the final position based on a position of a first carrier stop.
- Example 24 is an extension of Example 23 or any other example disclosed herein, further comprising detecting the final position of the ratchet carrier based on a sensor of the first carrier stop.
- Example 25 is an extension of Example 24 or any other example disclosed herein, further comprising maintaining a count of a number of doses of the liquid drug expelled based on detecting the final position of the ratchet carrier.
- Example 26 is an extension of Example 25 or any other example disclosed herein, further comprising rotating the ratchet gear in a second direction opposite the first direction from the final position to the initial position.
- Example 27 is an extension of Example 26 or any other example disclosed herein, further comprising decoupling the ratchet carrier from the ratchet gear prior to rotating the ratchet gear in the second direction, thereby preventing the ratchet gear and the lead screw from rotating in the second direction.
- Example 28 is an extension of Example 27 or any other example disclosed herein, further comprising restricting rotation of the ratchet carrier beyond the initial position based on a position of a second carrier stop.
- Example 29 is an extension of Example 28 or any other example disclosed herein, further comprising detecting the initial position of the ratchet carrier based on a sensor of the second carrier stop.
- The following examples pertain to further additional embodiments:
- Example 1 is a ratchet drive system, comprising a power source, an arm coupled to the power source, a pawl coupled to an end of the arm, a rack coupled to the arm through the pawl, and a plunger coupled to the end of the rack, the plunger positioned within a drug container storing a liquid drug.
- Example 2 is an extension of Example 1 or any other example disclosed herein, the power source configured to cause the arm to extend in a first direction, thereby moving the rack in the first direction.
- Example 3 is an extension of Example 2 or any other example disclosed herein, wherein the plunger is configured move in the first direction further into the drug container when the rack is moved in the first direction.
- Example 4 is an extension of Example 3 or any other example disclosed herein, wherein a portion of the liquid drug is expelled from the drug container when the plunger is moved in the first direction.
- Example 5 is an extension of Example 4 or any other example disclosed herein, wherein a predetermined dose of the liquid drug is expelled from the drug container when the arm is moved in the first direction from an initial position to a final position.
- Example 6 is an extension of Example 5 or any other example disclosed herein, wherein the final position corresponds to a maximum extension of the arm.
- Example 7 is an extension of Example 6 or any other example disclosed herein, wherein the pawl is configured to disengage the rack after the arm is in the final position.
- Example 8 is an extension of Example 7 or any other example disclosed herein, wherein the power source is configured to cause the arm to move in a second, opposite direction after the arm is in the final position.
- Example 9 is an extension of Example 8 or any other example disclosed herein, wherein the rack and the plunger are configured to remain stationary when the arm moves in the second direction.
- Example 10 is an extension of Example 9 or any other example disclosed herein, wherein the ratchet drive system is reset when the arm moves in the second direction to return to the initial position.
- Example 11 is an extension of Example 10 or any other example disclosed herein, wherein the pawl is configured to re-engage the rack when the ratchet drive system is reset.
- Example 12 is an extension of Example 11 or any other example disclosed herein, further comprising a controller for activating movement of the arm in the first direction and the second direction based on control of the power source.
- Example 13 is an extension of Example 12 or any other example disclosed herein, wherein the power source is a motor.
- Example 14 is an extension of Example 12 or any other example disclosed herein, wherein the power source is a linear actuator.
- Example 15 is an extension of Example 12 or any other example disclosed herein, wherein the controller is configured to maintain a count of a number of predetermined doses of the liquid drug that have been expelled based on the movement of the arm.
- Example 16 is an extension of Example 1 or any other example disclosed herein, wherein the drive system is part of an on-body delivery system (OBDS).
- Example 17 is a method comprising extending an arm in a first direction from an initial position to a final position, moving a rack in the first direction based on extending the arm, the rack coupled to a plunger positioned in a drug container holding a liquid drug, and moving the plunger in the first direction further into the drug container based on moving the rack, thereby expelling a dose of the liquid drug from the drug container.
- Example 18 is an extension of Example 17 or any other example disclosed herein, further comprising detecting the final position of the arm.
- Example 19 is an extension of Example 18 or any other example disclosed herein, further comprising maintaining a count of a number of doses of the liquid drug expelled based on detecting the final position of the arm.
- Example 20 is an extension of Example 19 or any other example disclosed herein, further comprising coupling the arm to the rack with a pawl.
- Example 21 is an extension of Example 20 or any other example disclosed herein, further comprising moving the pawl to decouple the arm from the rack after the arm is extended to its final position.
- Example 22 is an extension of Example 21 or any other example disclosed herein, further comprising rotating the pawl to decouple the arm from the rack after the arm is extended to its final position.
- Example 23 is an extension of Example 21 or any other example disclosed herein, further comprising moving the pawl in a direction away from the rack to decouple the arm from the rack after the arm is extended to its final position.
- Example 24 is an extension of Example 21 or any other example disclosed herein, further comprising moving the arm in a second direction opposite the first direction to retract the arm to the initial position from the final position.
- Example 25 is an extension of Example 24 or any other example disclosed herein, further comprising restricting movement of the rack and the plunger in the second direction.
- Certain embodiments of the present invention were described above. It is, however, expressly noted that the present invention is not limited to those embodiments, but rather the intention is that additions and modifications to what was expressly described herein are also included within the scope of the invention. Moreover, it is to be understood that the features of the various embodiments described herein were not mutually exclusive and can exist in various combinations and permutations, even if such combinations or permutations were not made express herein, without departing from the spirit and scope of the invention. In fact, variations, modifications, and other implementations of what was described herein will occur to those of ordinary skill in the art without departing from the spirit and the scope of the invention. As such, the invention is not to be defined only by the preceding illustrative description.
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/995,527 US20200376191A1 (en) | 2016-11-10 | 2020-08-17 | Ratchet drive for on body delivery system |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662420382P | 2016-11-10 | 2016-11-10 | |
US201662439822P | 2016-12-28 | 2016-12-28 | |
US15/809,491 US10780217B2 (en) | 2016-11-10 | 2017-11-10 | Ratchet drive for on body delivery system |
US16/995,527 US20200376191A1 (en) | 2016-11-10 | 2020-08-17 | Ratchet drive for on body delivery system |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/809,491 Continuation US10780217B2 (en) | 2016-11-10 | 2017-11-10 | Ratchet drive for on body delivery system |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200376191A1 true US20200376191A1 (en) | 2020-12-03 |
Family
ID=62065892
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/809,491 Active 2038-12-16 US10780217B2 (en) | 2016-11-10 | 2017-11-10 | Ratchet drive for on body delivery system |
US16/995,527 Pending US20200376191A1 (en) | 2016-11-10 | 2020-08-17 | Ratchet drive for on body delivery system |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/809,491 Active 2038-12-16 US10780217B2 (en) | 2016-11-10 | 2017-11-10 | Ratchet drive for on body delivery system |
Country Status (1)
Country | Link |
---|---|
US (2) | US10780217B2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1762259B1 (en) | 2005-09-12 | 2010-09-08 | Unomedical A/S | Inserter for an infusion set with a first and second spring units |
US10194938B2 (en) | 2011-03-14 | 2019-02-05 | UnoMedical, AS | Inserter system with transport protection |
US11357912B2 (en) | 2016-01-19 | 2022-06-14 | Unomedical A/S | Cannula and infusion devices |
EP3946522A1 (en) * | 2019-04-01 | 2022-02-09 | Credence Medsystems, Inc. | Polymeric injection systems |
WO2020233486A1 (en) * | 2019-05-17 | 2020-11-26 | Medtrum Technologies Inc. | Bilaterally driven drug infusion device with multiple infusion modes |
US20220339763A1 (en) * | 2019-05-17 | 2022-10-27 | Medtrum Technologies Inc. | Drug infusion device |
CN113950341B (en) | 2019-05-20 | 2024-03-19 | 优诺医疗有限公司 | Rotatable infusion device and method therefor |
WO2021012075A1 (en) * | 2019-07-19 | 2021-01-28 | Medtrum Technologies Inc. | Integrated drug infusion device |
CN112295050B (en) * | 2019-08-01 | 2023-06-06 | 上海移宇科技股份有限公司 | Drive device and drug infusion device |
US20220218895A1 (en) * | 2019-08-01 | 2022-07-14 | Medtrum Technologies Inc. | Driving apparatus and drug infusion device |
CN212491038U (en) * | 2020-03-18 | 2021-02-09 | 苏州天健云康信息科技有限公司 | Liquid drug delivery device |
EP4251235A4 (en) * | 2020-11-27 | 2024-08-21 | Medtrum Tech Inc | A driving structure of a drug infusion device |
US20230285680A1 (en) * | 2022-03-11 | 2023-09-14 | Altek Biotechnology Corporation | Driving mechanism for driving a plunger of an auto-injector to slide relative to a reservoir of the auto-injector and auto-injector therewith |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020029018A1 (en) * | 1996-03-30 | 2002-03-07 | Peter Jeffrey | Materials delivery device |
US20040210200A1 (en) * | 2003-04-16 | 2004-10-21 | Gerondale Scott J. | Controlled volume injection/aspiration device |
US20080070187A1 (en) * | 2006-09-14 | 2008-03-20 | Bisco, Inc. | Dispenser for dental compositions |
US20110259921A1 (en) * | 2008-03-27 | 2011-10-27 | Mccrone James Edward | Dispensing system |
Family Cites Families (239)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA606281A (en) | 1960-10-04 | Dann Morris | Cartridge for metering syringe | |
US1441508A (en) | 1921-12-06 | 1923-01-09 | Jensen Anton Marius | Cylindrical slide valve |
GB357139A (en) | 1929-06-14 | 1931-09-14 | Paul Von Vago | |
US2198666A (en) | 1936-09-30 | 1940-04-30 | Lakeland Foundation | Syringe |
GB810488A (en) | 1955-03-01 | 1959-03-18 | Eduard Woydt | Liquid pressure piston-engine or reciprocating pump |
GB875034A (en) | 1957-07-01 | 1961-08-16 | Renault | Improvements in or relating to valves for fluids under pressure |
US3176712A (en) | 1961-10-03 | 1965-04-06 | Ramsden Clement | Non-return valve |
US3297260A (en) | 1964-09-21 | 1967-01-10 | Conrad R Barlow | Nozzle and valve assembly |
US3505809A (en) | 1968-05-20 | 1970-04-14 | Thermal Hydraulics Corp | Thermal motor |
DE2127976A1 (en) | 1970-06-13 | 1971-12-23 | Ismatec SA, Zurich (Schweiz) | Dosing piston pump |
US3946732A (en) | 1973-08-08 | 1976-03-30 | Ampoules, Inc. | Two-chamber mixing syringe |
US3885662A (en) | 1973-12-26 | 1975-05-27 | Ibm | Steerable follower selection mechanism |
IL46017A (en) | 1974-11-07 | 1977-11-30 | Ampoules Inc | Two-chamber mixing syringe |
US3993061A (en) | 1975-02-28 | 1976-11-23 | Ivac Corporation | Syringe pump drive system and disposable syringe cartridge |
FR2348709A1 (en) | 1976-04-23 | 1977-11-18 | Pistor Michel | MESOTHERAPIC TREATMENT PROCESS AND INJECTION DEVICE, FORMING AUTOMATIC MICRO-INJECTOR, INCLUDING APPLICATION |
US4210173A (en) | 1976-12-06 | 1980-07-01 | American Hospital Supply Corporation | Syringe pumping system with valves |
US4152098A (en) | 1977-01-03 | 1979-05-01 | Clark Ivan P | Micropump |
DE2749251C3 (en) | 1977-11-03 | 1981-10-08 | Danfoss A/S, 6430 Nordborg | Adjustable heating device for small masses, especially the expansion means in heat setting devices |
FR2455269A1 (en) | 1978-01-17 | 1980-11-21 | Marceau Serge | Dynamic dosing of liquid food product - utilises compressed air operation of cylinders to move liquid dose to outlet |
US4221219A (en) | 1978-07-31 | 1980-09-09 | Metal Bellows Corporation | Implantable infusion apparatus and method |
US4265601A (en) | 1978-09-05 | 1981-05-05 | Harold Mandroian | Three valve precision pump apparatus with head pressure flowthrough protection |
US4257324A (en) | 1978-10-30 | 1981-03-24 | Bell & Howell Company | Position monitoring methods and apparatus |
EP0041563A4 (en) | 1979-12-13 | 1982-04-29 | Marvin P Loeb | Wearable insulin infusion system having a tubular reservoir and a positive displacement metering means. |
US4268150A (en) | 1980-01-28 | 1981-05-19 | Laurence Chen | Disposable camera with simplified film advance and indicator |
US4313439A (en) | 1980-03-24 | 1982-02-02 | Biotek, Inc. | Automated, spring-powered medicament infusion system |
CA1169323A (en) | 1980-06-03 | 1984-06-19 | Anthony M. Albisser | Insulin infusion device |
US4424720A (en) | 1980-12-15 | 1984-01-10 | Ivac Corporation | Mechanism for screw drive and syringe plunger engagement/disengagement |
IN155982B (en) | 1980-12-31 | 1985-04-20 | Choi Soo Bong | |
JPS57163309A (en) | 1981-04-01 | 1982-10-07 | Olympus Optical Co Ltd | Capsule apparatus for medical use |
FR2507637B1 (en) | 1981-06-16 | 1986-09-26 | Libero Elettrotecnica | THERMOELECTRIC ACTUATION DEVICE, IN PARTICULAR FOR ACTIVATING DISPENSERS OF DETERGENTS AND / OR GLOSS AGENTS IN WASHING MACHINES |
US4435173A (en) | 1982-03-05 | 1984-03-06 | Delta Medical Industries | Variable rate syringe pump for insulin delivery |
US4498843A (en) | 1982-08-02 | 1985-02-12 | Schneider Philip H | Insulin infusion pump |
US4551134A (en) | 1982-08-06 | 1985-11-05 | Nuvatec, Inc. | Intravenous set |
EP0143895B1 (en) | 1983-09-07 | 1987-12-23 | Disetronic Ag | Portable infusion apparatus |
NL8303908A (en) | 1983-11-15 | 1985-06-03 | Unilever Nv | METHOD AND APPARATUS FOR THE VOLUMETRIC DOSING OF VISCOUS PRODUCTS |
US4562751A (en) | 1984-01-06 | 1986-01-07 | Nason Clyde K | Solenoid drive apparatus for an external infusion pump |
US4678408A (en) | 1984-01-06 | 1987-07-07 | Pacesetter Infusion, Ltd. | Solenoid drive apparatus for an external infusion pump |
US4685903A (en) | 1984-01-06 | 1987-08-11 | Pacesetter Infusion, Ltd. | External infusion pump apparatus |
US4684368A (en) | 1984-06-01 | 1987-08-04 | Parker Hannifin Corporation | Inverted pump |
US4634427A (en) | 1984-09-04 | 1987-01-06 | American Hospital Supply Company | Implantable demand medication delivery assembly |
US4567549A (en) | 1985-02-21 | 1986-01-28 | Blazer International Corp. | Automatic takeup and overload protection device for shape memory metal actuator |
US4908017A (en) | 1985-05-14 | 1990-03-13 | Ivion Corporation | Failsafe apparatus and method for effecting syringe drive |
US4846797A (en) | 1985-05-14 | 1989-07-11 | Intelligent Medicine, Inc. | Syringe positioning device for enhancing fluid flow control |
DK160633C (en) | 1985-05-15 | 1991-09-02 | Henning Munk Ejlersen | HOSE PUMP, ISSUE FOR EVENING AS INSULIN PUMP |
US4689042A (en) | 1985-05-20 | 1987-08-25 | Survival Technology, Inc. | Automatic medicament ingredient mixing and injecting apparatus |
US4778451A (en) | 1986-03-04 | 1988-10-18 | Kamen Dean L | Flow control system using boyle's law |
US5349852A (en) | 1986-03-04 | 1994-09-27 | Deka Products Limited Partnership | Pump controller using acoustic spectral analysis |
US4766889A (en) | 1986-06-26 | 1988-08-30 | Medical Engineering Corporation | Infusion erectile system |
GB8701731D0 (en) | 1987-01-27 | 1987-03-04 | Patcentre Benelux Nv Sa | Pumps |
EP0315656B1 (en) | 1987-05-18 | 1993-07-07 | Disetronic Ag | Infusion apparatus |
US4898579A (en) | 1987-06-26 | 1990-02-06 | Pump Controller Corporation | Infusion pump |
US4858619A (en) | 1987-06-29 | 1989-08-22 | Toth Marie A | Intracranial pressure monitoring system |
US5062841A (en) | 1988-08-12 | 1991-11-05 | The Regents Of The University Of California | Implantable, self-regulating mechanochemical insulin pump |
US5222362A (en) | 1989-01-10 | 1993-06-29 | Maus Daryl D | Heat-activated drug delivery system and thermal actuators therefor |
US5205819A (en) | 1989-05-11 | 1993-04-27 | Bespak Plc | Pump apparatus for biomedical use |
US5020325A (en) | 1990-02-13 | 1991-06-04 | Procedes Vernet | Heat motor |
US5097122A (en) | 1990-04-16 | 1992-03-17 | Pacesetter Infusion, Ltd. | Medication infusion system having optical motion sensor to detect drive mechanism malfunction |
US5007458A (en) | 1990-04-23 | 1991-04-16 | Parker Hannifin Corporation | Poppet diaphragm valve |
JPH0451966A (en) | 1990-06-19 | 1992-02-20 | Toichi Ishikawa | Medical fluid continuous injector |
GB9027859D0 (en) | 1990-12-21 | 1991-02-13 | Cmb Foodcan Plc | Metering apparatus |
US5236416A (en) | 1991-05-23 | 1993-08-17 | Ivac Corporation | Syringe plunger position detection and alarm generation |
US5213483A (en) | 1991-06-19 | 1993-05-25 | Strato Medical Corporation | Peristaltic infusion pump with removable cassette and mechanically keyed tube set |
DE4129271C1 (en) | 1991-09-03 | 1992-09-17 | Fresenius Ag, 6380 Bad Homburg, De | |
DE4200595C2 (en) | 1992-01-13 | 1994-10-13 | Michail Efune | Assembly for the infusion set for an insulin pump |
US5911716A (en) | 1992-01-24 | 1999-06-15 | I-Flow Corporation | Platen pump |
US5267956A (en) | 1992-02-05 | 1993-12-07 | Alcon Surgical, Inc. | Surgical cassette |
US5346476A (en) | 1992-04-29 | 1994-09-13 | Edward E. Elson | Fluid delivery system |
US5261884A (en) | 1992-04-29 | 1993-11-16 | Becton, Dickinson And Company | Syringe pump control system |
JPH0663133A (en) | 1992-06-18 | 1994-03-08 | Raifu Technol Kenkyusho | Portable automatic infusion injector |
DE4241943C2 (en) | 1992-12-11 | 1994-12-01 | Busak & Luyken Gmbh & Co | Closure means and sealing valve for container openings |
CH685461B5 (en) | 1993-01-05 | 1996-01-31 | Jean Claude Berney | liquid substances therapeutic infusion sets and portable device comprising such a device. |
US5433710A (en) | 1993-03-16 | 1995-07-18 | Minimed, Inc. | Medication infusion pump with fluoropolymer valve seat |
DE4310808C2 (en) | 1993-04-02 | 1995-06-22 | Boehringer Mannheim Gmbh | Liquid dosing system |
US5261882A (en) | 1993-04-26 | 1993-11-16 | Sealfon Andrew I | Negator spring-powered syringe |
DE69431994T2 (en) | 1993-10-04 | 2003-10-30 | Res Int Inc | MICRO-MACHINED FLUID TREATMENT DEVICE WITH FILTER AND CONTROL VALVE |
US5807075A (en) | 1993-11-23 | 1998-09-15 | Sarcos, Inc. | Disposable ambulatory microprocessor controlled volumetric pump |
US5582593A (en) | 1994-07-21 | 1996-12-10 | Hultman; Barry W. | Ambulatory medication delivery system |
US5520661A (en) | 1994-07-25 | 1996-05-28 | Baxter International Inc. | Fluid flow regulator |
CA2154937A1 (en) | 1994-07-29 | 1996-01-30 | John C. Tanner | System for administration of a liquid agent to a patient with a syringe pump |
JPH0858897A (en) | 1994-08-12 | 1996-03-05 | Japan Storage Battery Co Ltd | Fluid supply device |
US5637095A (en) | 1995-01-13 | 1997-06-10 | Minimed Inc. | Medication infusion pump with flexible drive plunger |
US5665070A (en) | 1995-01-19 | 1997-09-09 | I-Flow Corporation | Infusion pump with magnetic bag compression |
JP2697663B2 (en) | 1995-03-04 | 1998-01-14 | 株式会社ニッショー | Multiple chemical solution injection tool |
FR2731475B1 (en) | 1995-03-07 | 1997-05-30 | Thomson Dauphinoise | DEVICE FOR MOUNTING AN ELECTRIC HEATING AND / OR COOLING COMPONENT ON A THERMAL CYLINDER |
US5503628A (en) | 1995-03-15 | 1996-04-02 | Jettek, Inc. | Patient-fillable hypodermic jet injector |
EP0821566B1 (en) | 1995-04-20 | 2003-10-15 | ACIST Medical Systems, Inc. | Angiographic injector |
US5618269A (en) | 1995-05-04 | 1997-04-08 | Sarcos, Inc. | Pressure-driven attachable topical fluid delivery system |
WO1997005385A1 (en) | 1995-07-27 | 1997-02-13 | Seiko Epson Corporation | Microvalve and method of manufacturing the same, micropump using the microvalve and method of manufacturing the same, and apparatus using the micropump |
US5779676A (en) | 1995-10-11 | 1998-07-14 | Science Incorporated | Fluid delivery device with bolus injection site |
US5776103A (en) | 1995-10-11 | 1998-07-07 | Science Incorporated | Fluid delivery device with bolus injection site |
US6050457A (en) | 1995-12-06 | 2000-04-18 | The Procter & Gamble Company | High pressure manually-actuated spray pump |
US5976109A (en) | 1996-04-30 | 1999-11-02 | Medtronic, Inc. | Apparatus for drug infusion implanted within a living body |
US5785688A (en) | 1996-05-07 | 1998-07-28 | Ceramatec, Inc. | Fluid delivery apparatus and method |
IL118689A (en) | 1996-06-20 | 2000-10-31 | Gadot Amir | Intravenous infusion apparatus |
US5748827A (en) | 1996-10-23 | 1998-05-05 | University Of Washington | Two-stage kinematic mount |
US6883778B1 (en) | 1996-11-18 | 2005-04-26 | Nypro Inc. | Apparatus for reducing fluid drawback through a medical valve |
CH692240A5 (en) | 1997-03-26 | 2002-04-15 | Disetronic Licensing Ag | Catheter system for transdermal passage devices. |
CN1179983A (en) | 1997-06-03 | 1998-04-29 | 王坤山 | Medical device composed of elastic valve type bottle plug and puncture needle |
DE19723648C1 (en) | 1997-06-05 | 1998-08-27 | Disetronic Licensing Ag | Controlled infusion equipment with leak and reverse flow prevention used e.g. in insulin therapy |
US5957890A (en) | 1997-06-09 | 1999-09-28 | Minimed Inc. | Constant flow medication infusion pump |
US5954643A (en) | 1997-06-09 | 1999-09-21 | Minimid Inc. | Insertion set for a transcutaneous sensor |
US6485462B1 (en) | 1997-08-27 | 2002-11-26 | Science Incorporated | Fluid delivery device with heat activated energy source |
US6527744B1 (en) | 1997-08-27 | 2003-03-04 | Science Incorporated | Fluid delivery device with light activated energy source |
US6200293B1 (en) | 1997-08-27 | 2001-03-13 | Science Incorporated | Fluid delivery device with temperature controlled energy source |
US5961492A (en) | 1997-08-27 | 1999-10-05 | Science Incorporated | Fluid delivery device with temperature controlled energy source |
US6569115B1 (en) | 1997-08-28 | 2003-05-27 | Mdc Investment Holdings, Inc. | Pre-filled retractable needle injection device |
WO1999010049A1 (en) | 1997-08-29 | 1999-03-04 | Cycle-Ops Products, Inc. | Exercise resistance device |
US6019747A (en) | 1997-10-21 | 2000-02-01 | I-Flow Corporation | Spring-actuated infusion syringe |
EP1131118A1 (en) | 1997-12-19 | 2001-09-12 | Phiscience GmbH, Entwicklung von Sensoren | Portable device and method for the mobile supply of medicaments with wireless transmission of data for control or programming purposes |
US5897530A (en) | 1997-12-24 | 1999-04-27 | Baxter International Inc. | Enclosed ambulatory pump |
US6159188A (en) | 1998-01-14 | 2000-12-12 | Robert L. Rogers | Apparatus and method for delivery of micro and submicro quantities of materials |
EP1058565B1 (en) | 1998-02-02 | 2003-05-02 | Medtronic, Inc. | Implantable drug infusion device having a safety valve |
AU3050499A (en) | 1998-03-23 | 1999-10-18 | Elan Corporation, Plc | Drug delivery device |
US5919167A (en) | 1998-04-08 | 1999-07-06 | Ferring Pharmaceuticals | Disposable micropump |
AU7785998A (en) | 1998-06-04 | 1999-12-20 | Elan Corporation, Plc | Gas driven drug delivery device |
US5906597A (en) | 1998-06-09 | 1999-05-25 | I-Flow Corporation | Patient-controlled drug administration device |
US5993423A (en) | 1998-08-18 | 1999-11-30 | Choi; Soo Bong | Portable automatic syringe device and injection needle unit thereof |
US6375638B2 (en) | 1999-02-12 | 2002-04-23 | Medtronic Minimed, Inc. | Incremental motion pump mechanisms powered by shape memory alloy wire or the like |
US20040069044A1 (en) | 1999-04-29 | 2004-04-15 | Gilad Lavi | Device for measuring a volume of drug |
EP1183059A1 (en) | 1999-06-08 | 2002-03-06 | Medical Research Group, Inc. | Method and apparatus for infusing liquids using a chemical reaction in an implanted infusion device |
EP2309130B1 (en) | 1999-06-28 | 2016-08-10 | California Institute of Technology | Microfabricated elastomeric valve and pump systems |
US6635014B2 (en) | 2000-01-21 | 2003-10-21 | Timothy J. Starkweather | Ambulatory medical apparatus and method having telemetry modifiable control software |
US7003336B2 (en) | 2000-02-10 | 2006-02-21 | Medtronic Minimed, Inc. | Analyte sensor method of making the same |
AU2001250924A1 (en) | 2000-03-22 | 2001-10-03 | Docusys, Inc. | A drug delivery and monitoring system |
TW523415B (en) | 2000-03-24 | 2003-03-11 | Novo Nordisk As | A flexible piston rod |
US6485461B1 (en) | 2000-04-04 | 2002-11-26 | Insulet, Inc. | Disposable infusion device |
US6585699B2 (en) | 2000-04-13 | 2003-07-01 | Nna/S | Drug delivery device provided with a one-way mechanism |
US6494433B2 (en) | 2000-06-06 | 2002-12-17 | The Regents Of The University Of Michigan | Thermally activated polymer device |
US6589229B1 (en) | 2000-07-31 | 2003-07-08 | Becton, Dickinson And Company | Wearable, self-contained drug infusion device |
ES2287156T3 (en) | 2000-09-08 | 2007-12-16 | Insulet Corporation | DEVICES AND SYSTEMS FOR THE INFUSION OF A PATIENT. |
US6363609B1 (en) | 2000-10-20 | 2002-04-02 | Short Block Technologies, Inc. | Method and apparatus for aligning crankshaft sections |
US6644944B2 (en) | 2000-11-06 | 2003-11-11 | Nanostream, Inc. | Uni-directional flow microfluidic components |
ATE352333T1 (en) | 2000-11-09 | 2007-02-15 | Insulet Corp | DEVICE FOR TRANSCUTANEOUS DELIVERY OF MEDICATIONS |
US6537249B2 (en) | 2000-12-18 | 2003-03-25 | Science, Incorporated | Multiple canopy |
EP1364125A1 (en) | 2001-01-17 | 2003-11-26 | M 2 Medical A/S | Shape memory alloy actuator |
GB0107601D0 (en) | 2001-03-27 | 2001-05-16 | Dca Design Int Ltd | Improvements in and relating to and injection device |
EP2140891B1 (en) | 2001-05-18 | 2013-03-27 | DEKA Products Limited Partnership | Conduit for coupling to a fluid delivery device |
US7235063B2 (en) | 2001-08-21 | 2007-06-26 | D'antonio Consultants International, Inc. | Hypodermic injection system |
US20040094733A1 (en) | 2001-08-31 | 2004-05-20 | Hower Robert W. | Micro-fluidic system |
NL1019126C1 (en) | 2001-10-05 | 2003-04-08 | Fondse Valves B V | Dosing pump for e.g. measuring intercellular moisture, contains pump chamber with ejector and sliding part for sealing inlet and outlet ports |
US20040078028A1 (en) | 2001-11-09 | 2004-04-22 | Flaherty J. Christopher | Plunger assembly for patient infusion device |
US20030109827A1 (en) | 2001-12-07 | 2003-06-12 | Elan Pharma International Limited | Drug delivery system and method |
US6878136B2 (en) | 2002-02-28 | 2005-04-12 | Medical Product Specialists | Huber needle with anti-rebound safety mechanism |
US7678084B2 (en) | 2002-03-18 | 2010-03-16 | Eli Lilly And Company | Medication dispensing apparatus with gear set for mechanical advantage |
CN1375338A (en) | 2002-03-22 | 2002-10-23 | 张�浩 | Heating infusion device |
US6656159B2 (en) | 2002-04-23 | 2003-12-02 | Insulet Corporation | Dispenser for patient infusion device |
US20040153032A1 (en) * | 2002-04-23 | 2004-08-05 | Garribotto John T. | Dispenser for patient infusion device |
US6960192B1 (en) | 2002-04-23 | 2005-11-01 | Insulet Corporation | Transcutaneous fluid delivery system |
US6656158B2 (en) | 2002-04-23 | 2003-12-02 | Insulet Corporation | Dispenser for patient infusion device |
US20050238507A1 (en) | 2002-04-23 | 2005-10-27 | Insulet Corporation | Fluid delivery device |
GB0211294D0 (en) | 2002-05-17 | 2002-06-26 | Owen Mumford Ltd | Improvements relating to injection devices |
US7160272B1 (en) | 2002-05-31 | 2007-01-09 | Elcam Plastic | Y-site medical valve |
US6723072B2 (en) | 2002-06-06 | 2004-04-20 | Insulet Corporation | Plunger assembly for patient infusion device |
US20040010207A1 (en) | 2002-07-15 | 2004-01-15 | Flaherty J. Christopher | Self-contained, automatic transcutaneous physiologic sensing system |
US7018360B2 (en) | 2002-07-16 | 2006-03-28 | Insulet Corporation | Flow restriction system and method for patient infusion device |
US6749407B2 (en) | 2002-08-22 | 2004-06-15 | Motorola, Inc. | Method of installing valves in a micro-pump |
EP1403519A1 (en) | 2002-09-27 | 2004-03-31 | Novo Nordisk A/S | Membrane pump with stretchable pump membrane |
US7144384B2 (en) | 2002-09-30 | 2006-12-05 | Insulet Corporation | Dispenser components and methods for patient infusion device |
US7128727B2 (en) | 2002-09-30 | 2006-10-31 | Flaherty J Christopher | Components and methods for patient infusion device |
US20040068224A1 (en) | 2002-10-02 | 2004-04-08 | Couvillon Lucien Alfred | Electroactive polymer actuated medication infusion pumps |
EP1583571B1 (en) | 2002-12-23 | 2008-02-13 | M2 Medical A/S | Medical dispensing device for insulin |
JP2004247271A (en) | 2003-02-12 | 2004-09-02 | Bimetal Japan Kk | Voltage sensing switch |
JP2004274719A (en) | 2003-02-18 | 2004-09-30 | Fujitsu Hitachi Plasma Display Ltd | Predriver circuit, capacitive load drive circuit, and plasma display |
US20050022274A1 (en) | 2003-04-18 | 2005-01-27 | Robert Campbell | User interface for infusion pump remote controller and method of using the same |
JP2007511252A (en) | 2003-06-09 | 2007-05-10 | ニプロ ダイアビティーズ システムズ,インコーポレイテッド | Coupling system in infusion pump |
DE10327254B4 (en) | 2003-06-17 | 2010-01-28 | Disetronic Licensing Ag | Modular infusion pump |
JP4047803B2 (en) | 2003-12-25 | 2008-02-13 | 日機装株式会社 | Diaphragm pump |
HUE025052T2 (en) | 2004-03-08 | 2016-01-28 | Ichor Medical Systems Inc | Improved apparatus for electrically mediated delivery of therapeutic agents |
US7507221B2 (en) | 2004-10-13 | 2009-03-24 | Mallinckrodt Inc. | Powerhead of a power injection system |
JP2006159228A (en) | 2004-12-06 | 2006-06-22 | Mitsubishi Heavy Ind Ltd | Brazing method for heat exchanger and preheating apparatus for brazing |
US7470237B2 (en) | 2005-01-10 | 2008-12-30 | Ethicon Endo-Surgery, Inc. | Biopsy instrument with improved needle penetration |
US20060173439A1 (en) | 2005-01-18 | 2006-08-03 | Thorne Gale H Jr | Syringe drive system |
US20060178633A1 (en) | 2005-02-03 | 2006-08-10 | Insulet Corporation | Chassis for fluid delivery device |
JP4997708B2 (en) | 2005-03-08 | 2012-08-08 | Dic株式会社 | Method for producing fluorinated alkyl group-containing oligomer |
US20060253085A1 (en) | 2005-05-06 | 2006-11-09 | Medtronic Minimed, Inc. | Dual insertion set |
US7691086B2 (en) | 2005-06-14 | 2010-04-06 | Tengiz Tkebuchava | Catheter for introduction of medications to the tissues of a heart or other organ |
GB2433032A (en) | 2005-12-08 | 2007-06-13 | Owen Mumford Ltd | Syringe with dose adjustment means |
EP1993633B1 (en) | 2006-02-09 | 2016-11-09 | Deka Products Limited Partnership | Pumping fluid delivery systems and methods using force application assembly |
WO2007115039A2 (en) | 2006-03-30 | 2007-10-11 | Valeritas, Llc | Multi-cartridge fluid delivery device |
WO2007137930A1 (en) | 2006-05-29 | 2007-12-06 | Novo Nordisk A/S | Mechanism for injection device |
US20070282269A1 (en) | 2006-05-31 | 2007-12-06 | Seattle Medical Technologies | Cannula delivery apparatus and method for a disposable infusion device |
US9119582B2 (en) | 2006-06-30 | 2015-09-01 | Abbott Diabetes Care, Inc. | Integrated analyte sensor and infusion device and methods therefor |
US7455663B2 (en) | 2006-08-23 | 2008-11-25 | Medtronic Minimed, Inc. | Infusion medium delivery system, device and method with needle inserter and needle inserter device and method |
US20080172028A1 (en) | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump having selectable insulin absorption models |
GB2443261B (en) | 2006-10-26 | 2009-04-22 | Starbridge Systems Ltd | Wax micro actuator |
ITPD20060419A1 (en) | 2006-11-13 | 2008-05-14 | Federico Nalesso | DEVICE FOR THE MAINTENANCE TREATMENT OF CENTRAL VENOUS CATHETERS |
DE102007018868A1 (en) | 2007-04-19 | 2008-10-23 | Lts Lohmann Therapie-Systeme Ag | Disposable injector with at least one towing hook and a sliding wedge gear for unlocking releasing a locking element |
JP5277242B2 (en) | 2007-04-30 | 2013-08-28 | メドトロニック ミニメド インコーポレイテッド | Needle insertion and fluid flow connections for infusion medium delivery systems |
DK2146760T3 (en) | 2007-04-30 | 2019-01-28 | Medtronic Minimed Inc | FILLING OF RESERVOIR, BUBBLE MANAGEMENT AND DELIVERY SYSTEMS FOR INFUSION MEDIA AND PROCEDURES |
US8211059B2 (en) | 2007-06-25 | 2012-07-03 | Kriesel Marshall S | Fluid dispenser with additive sub-system |
US9968742B2 (en) | 2007-08-29 | 2018-05-15 | Medtronic Minimed, Inc. | Combined sensor and infusion set using separated sites |
CN101951975B (en) | 2007-09-17 | 2013-06-19 | 萨蒂什·桑达尔 | High precision infusion pumps |
US7771392B2 (en) * | 2007-11-29 | 2010-08-10 | Roche Diagnostics Operations, Inc. | Lead screw delivery device using reusable shape memory actuator drive |
SG172114A1 (en) | 2008-12-12 | 2011-07-28 | Sanofi Aventis Deutschland | Resettable drive mechanism for a medication delivery device and medication delivery device |
US9370621B2 (en) | 2008-12-16 | 2016-06-21 | Medtronic Minimed, Inc. | Needle insertion systems and methods |
WO2010139793A1 (en) | 2009-06-04 | 2010-12-09 | Novo Nordisk A/S | Mixing device with piston coupling arrangement |
EP2932994B1 (en) | 2009-07-30 | 2017-11-08 | Tandem Diabetes Care, Inc. | New o-ring seal, and delivery mechanism and portable infusion pump system related thereto |
US8900190B2 (en) | 2009-09-02 | 2014-12-02 | Medtronic Minimed, Inc. | Insertion device systems and methods |
KR101494950B1 (en) | 2009-11-03 | 2015-02-23 | 에프. 호프만-라 로슈 아게 | Device for almost germ-free provision of a fluid medium |
CN102762243B (en) | 2009-12-14 | 2014-07-23 | Shl集团有限责任公司 | Medicament delivery device |
WO2011114285A2 (en) | 2010-03-17 | 2011-09-22 | Sensile Pat Ag | Micropump |
IL211800A (en) | 2010-03-21 | 2014-03-31 | Isaac Zukier | Device for injecting fluids or gels |
CN103118737B (en) | 2010-04-21 | 2015-05-20 | 艾伯维生物技术有限公司 | Wearable automatic injection device for controlled delivery of therapeutic agents |
DK2397181T3 (en) | 2010-06-18 | 2014-03-31 | Hoffmann La Roche | Insertion device with a permanently lockable and rotatable needle cover means |
US9950113B2 (en) | 2010-11-03 | 2018-04-24 | Sanofi-Aventis Deutschland Gmbh | Needle assembly for the delivery of at least two medicaments |
GB201020472D0 (en) | 2010-12-02 | 2011-01-19 | Oval Medical Technologies Ltd | A drive assembly for an autoinjector |
EP2468338A1 (en) | 2010-12-21 | 2012-06-27 | Sanofi-Aventis Deutschland GmbH | Auto-injector |
DK2686047T3 (en) | 2011-03-16 | 2021-08-23 | Sanofi Aventis Deutschland | DRIVE MECHANISM FOR MEDICINE DELIVERY DEVICE AND MEDICINE DELIVERY DEVICE |
CA2829507A1 (en) | 2011-03-31 | 2012-10-04 | Sanofi-Aventis Deutschland Gmbh | Dosing mechanism |
CN107096098A (en) | 2011-04-21 | 2017-08-29 | 艾伯维公司 | Wearable automatic injection device |
JP5853289B2 (en) | 2011-04-26 | 2016-02-09 | 大成化工株式会社 | Elastic seal body for prefilled syringe |
US8499913B2 (en) | 2011-05-20 | 2013-08-06 | The Boeing Company | Shape memory alloy actuator system and method |
BR112014004530A2 (en) | 2011-09-02 | 2017-03-28 | Unitract Syringe Pty Ltd | drive mechanism for integrated state indication drug delivery pumps |
JP5861341B2 (en) | 2011-09-12 | 2016-02-16 | 頴 小西 | Pump device |
EP2572740A1 (en) | 2011-09-20 | 2013-03-27 | Roche Diagnostics GmbH | Drug injection devices and systems with an analyte measurement module |
US10155090B2 (en) | 2011-10-07 | 2018-12-18 | Novo Nordisk A/S | System for determining position of an element in relation to another element using magnetic fields |
US8382703B1 (en) | 2011-10-18 | 2013-02-26 | King Saud University | Piezoelectric dual-syringe insulin pump |
EP2626097A1 (en) | 2012-02-09 | 2013-08-14 | Arte Corporation | Device for accomodating a freeze-dried pharmaceutical product and method of manufacturing a sealed vessel accomodating a freeze-dried pharmaceutical product |
JP6368703B2 (en) | 2012-03-15 | 2018-08-01 | ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company | Multi-use disposable injection pen |
RS65875B1 (en) | 2012-03-30 | 2024-09-30 | Insulet Corp | Fluid delivery device with transcutaneous access tool, insertion mechanism and blood glucose monitoring for use therewith |
US20150202386A1 (en) | 2012-08-28 | 2015-07-23 | Osprey Medical, Inc. | Volume monitoring device utilizing hall sensor-based systems |
US20150290389A1 (en) | 2012-12-10 | 2015-10-15 | Sanofi-Aventis Deutschland Gmbh | Medical pump and method of operating the same |
DE102012024371A1 (en) | 2012-12-13 | 2014-06-18 | Schott Ag | Storage device Storage of liquid media, in particular medicines and methods for dispensing liquid media |
EP2968784B1 (en) | 2013-03-13 | 2021-11-24 | Sanofi-Aventis Deutschland GmbH | Assembly for a drug delivery device comprising a feedback feature |
EP2976117B1 (en) | 2013-03-22 | 2020-12-30 | Amgen Inc. | Injector and method of assembly |
CN110115787A (en) | 2013-08-23 | 2019-08-13 | 尤尼特拉克特注射器公司 | Integrated puncturing for medicine delivery pump seals fluid passage connector and drug container |
WO2015032772A1 (en) | 2013-09-03 | 2015-03-12 | Sanofi | Mechanism for a drug delivery device and drug delivery device comprising the mechanism |
MX2016007050A (en) | 2013-12-01 | 2017-05-25 | Becton Dickinson Co | Medicament device. |
JP6647205B2 (en) | 2014-02-06 | 2020-02-14 | ノボ・ノルデイスク・エー/エス | Combined cartridge and needle assembly |
US10004845B2 (en) | 2014-04-18 | 2018-06-26 | Becton, Dickinson And Company | Split piston metering pump |
WO2015164648A1 (en) | 2014-04-24 | 2015-10-29 | Becton, Dickinson And Company | Catheter insertion mechanism for a patch pump |
CN206642180U (en) | 2014-04-24 | 2017-11-17 | 贝克顿·迪金森公司 | Infusion device |
KR101524678B1 (en) | 2014-04-29 | 2015-06-03 | 최규동 | Short Length Driver for Injection Appartus |
CN106535857B (en) | 2014-05-19 | 2019-07-09 | 美迪康创新合伙人股份公司 | Medical cylindrantherae including check valve |
EP3191155A4 (en) | 2014-09-10 | 2018-08-29 | Becton Dickinson and Company | Activation system and method for on-body medical devices |
GB201600234D0 (en) | 2016-01-06 | 2016-02-17 | Vicentra B V | Shape memory actuator |
MX2018009239A (en) | 2016-01-28 | 2019-02-07 | Deka Products Lp | Apparatus for monitoring, regulating, or controlling fluid flow. |
GB2549750A (en) | 2016-04-27 | 2017-11-01 | Owen Mumford Ltd | Medicament delivery device |
US10709845B2 (en) | 2016-07-21 | 2020-07-14 | Amgen Inc. | Drug delivery device with a rotatable drive mechanism |
-
2017
- 2017-11-10 US US15/809,491 patent/US10780217B2/en active Active
-
2020
- 2020-08-17 US US16/995,527 patent/US20200376191A1/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020029018A1 (en) * | 1996-03-30 | 2002-03-07 | Peter Jeffrey | Materials delivery device |
US20040210200A1 (en) * | 2003-04-16 | 2004-10-21 | Gerondale Scott J. | Controlled volume injection/aspiration device |
US20080070187A1 (en) * | 2006-09-14 | 2008-03-20 | Bisco, Inc. | Dispenser for dental compositions |
US20110259921A1 (en) * | 2008-03-27 | 2011-10-27 | Mccrone James Edward | Dispensing system |
Also Published As
Publication number | Publication date |
---|---|
US10780217B2 (en) | 2020-09-22 |
US20180126068A1 (en) | 2018-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200376191A1 (en) | Ratchet drive for on body delivery system | |
EP1909870B2 (en) | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left | |
EP2125081B1 (en) | An injection device comprising a locking nut | |
EP3057629B1 (en) | Drug delivery device with brake mechanism | |
EP2451508B1 (en) | Frost protected injection device | |
US12109398B2 (en) | Torsion spring driven injection device | |
CN104519929B (en) | Medicament delivery device | |
US20160228651A1 (en) | Drug Delivery Device with Improved Dose Reset Mechanism | |
JP2018531702A5 (en) | ||
JP2013528083A5 (en) | ||
JP2013506465A5 (en) | ||
US20160256631A1 (en) | Drug Delivery Device with Front Loading Feature | |
EP3261689B1 (en) | Drug delivery device with dose reset mechanism | |
EP3019221B1 (en) | Control of plunger position in an injection device | |
JP6743065B2 (en) | Drug delivery device with priming mechanism | |
JP2016529047A5 (en) | ||
EP3509673B1 (en) | Dose delivery mechanism | |
CN108136126B (en) | Drug delivery device with a slim drive mechanism | |
EP3509675B1 (en) | Dose setting and indicator mechanism |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: INSULET CORPORATION, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NAZZARO, DAVID;KOZIN, SIMON;MCCAFFREY, MAUREEN;SIGNING DATES FROM 20180328 TO 20180426;REEL/FRAME:053536/0635 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT, MARYLAND Free format text: SECURITY INTEREST;ASSIGNOR:INSULET CORPORATION;REEL/FRAME:056135/0974 Effective date: 20210504 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |